{"id":"qld:sl-1987-dmr","name":"Drugs Misuse Regulation 1987","slug":"drugs-misuse-regulation-1987","collection":"regulation","jurisdiction":"qld","status":"in_force","isInForce":true,"actNumber":"dmr of 1987","makingDate":null,"administeringDepartment":null,"currentVersion":{"id":175896,"registerId":"qld-qld:sl-1987-dmr-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":0},{"sectionNumber":"sec.1","sectionType":"section","heading":"Short title","content":"### sec.1 Short title\n\nThis regulation may be cited as the Drugs Misuse Regulation 1987 .","sortOrder":1},{"sectionNumber":"sec.2","sectionType":"section","heading":"Dictionary","content":"### sec.2 Dictionary\n\nThe dictionary in schedule 9 defines particular words used in this regulation.\ns 2 prev s 2 amd 1996 SL No. 309 s 5 (1) ; om 8 November 1996 RA s 37\npres s 2 (prev s 4) sub 1998 SL No. 348 s 3 (2)\nrenum 2002 No. 255 s 3\ns 2 def occupier’s notice reloc to sch 9 1998 SL No. 348 s 3 (1)\ns 2 def record of proceedings reloc to sch 9 1998 SL No. 348 s 3 (1)\ns 2 def search warrant reloc to sch 9 1998 SL No. 348 s 3 (1)\ns 2 def supply ins 1996 SL No. 309 s 5 (3)\nom 1998 SL No. 348 s 3 (2)\ns 2 def the Act sub 1989 reg pubd gaz 6 May 1989 pp 230–1\nom 1996 SL No. 309 s 5 (2)","sortOrder":2},{"sectionNumber":"pt.2","sectionType":"part","heading":"Syringes and dangerous drugs disposal procedures","content":"# Syringes and dangerous drugs disposal procedures","sortOrder":3},{"sectionNumber":"sec.3","sectionType":"section","heading":"Prescribed procedures for the disposal of hypodermic syringes and needles","content":"### sec.3 Prescribed procedures for the disposal of hypodermic syringes and needles\n\nFor the purposes of section 10 (4A) of the Act , the prescribed procedures for the disposal of a hypodermic syringe or needle are—\nby placing the hypodermic syringe or needle in a rigid wall, puncture resistant container and that container is sealed or securely closed in such a manner that its contents are incapable of causing injury to any person; or\nby giving the hypodermic syringe or needle to a person who is a medical practitioner, pharmacist or person or a member of a class of persons referred to as authorised in section 10 (3) of the Act .\ns 3 ins reg pubd gaz 6 May 1989 pp 230–1\nrenum 2002 SL No. 255 s 5 (2)\namd 2009 SL No. 99 s 3\n- (a) by placing the hypodermic syringe or needle in a rigid wall, puncture resistant container and that container is sealed or securely closed in such a manner that its contents are incapable of causing injury to any person; or\n- (b) by giving the hypodermic syringe or needle to a person who is a medical practitioner, pharmacist or person or a member of a class of persons referred to as authorised in section 10 (3) of the Act .","sortOrder":4},{"sectionNumber":"sec.4","sectionType":"section","heading":"Prescribed procedure for disposal of dangerous drugs","content":"### sec.4 Prescribed procedure for disposal of dangerous drugs\n\nFor the purposes of section 125 of the Act , the prescribed procedure for the disposal of a thing is—\nin the case where the thing is a trace amount of a dangerous drug contained in a hypodermic syringe or needle, by disposing of the hypodermic syringe or needle in accordance with the procedures prescribed in section 3 ; or\nin any other case, at the first reasonable opportunity, by giving—\nsuch thing; and\nwhere such thing is contained in a hypodermic syringe or needle, such syringe or needle;\nto an inspector under the Medicines and Poisons Act 2019 .\ns 4 (prev s 10) ins reg pubd gaz 6 May 1989 pp 230–1\nrenum 2002 SL No. 255 s 5 (2)\namd 2006 SL No. 71 s 4 ; 2008 Act No. 4 s 34 ; 2009 SL No. 99 s 4 ; amd 2021 SL No. 141 s 93 sch 8\n- (a) in the case where the thing is a trace amount of a dangerous drug contained in a hypodermic syringe or needle, by disposing of the hypodermic syringe or needle in accordance with the procedures prescribed in section 3 ; or\n- (b) in any other case, at the first reasonable opportunity, by giving— (i) such thing; and (ii) where such thing is contained in a hypodermic syringe or needle, such syringe or needle; to an inspector under the Medicines and Poisons Act 2019 .\n- (i) such thing; and\n- (ii) where such thing is contained in a hypodermic syringe or needle, such syringe or needle;\n- (i) such thing; and\n- (ii) where such thing is contained in a hypodermic syringe or needle, such syringe or needle;","sortOrder":5},{"sectionNumber":"pt.3","sectionType":"part","heading":"Controlled substances","content":"# Controlled substances","sortOrder":6},{"sectionNumber":"sec.5","sectionType":"section","heading":"Other act that is a relevant transaction— Act , s 43C (b)","content":"### sec.5 Other act that is a relevant transaction— Act , s 43C (b)\n\nAny act by which a controlled substance is supplied by a person, in or in connection with the person’s business, to anyone else is a relevant transaction for the supply of a controlled substance.\nA and B are partners in a chain of pharmacies. They make cold tablets to sell in the pharmacies by compounding ephedrine (a controlled substance) with other substances.\nThe partners sell some of the left over ephedrine to a pharmaceutical research company and give the rest away.\nBoth the sale and gift of ephedrine are relevant transactions.\nUnder section 43A of the Act —\nsupply means give, distribute, sell or supply.\ns 5 prev s 5 amd 1996 SL No. 309 s 7\nom 2002 SL No. 255 s 4\npres s 5 (prev s 11) ins 1996 SL No. 309 s 12\nrenum 2002 SL No. 255 s 5 (2)","sortOrder":7},{"sectionNumber":"sec.6","sectionType":"section","heading":"Documents and proof of identity required for supply of a controlled substance or controlled thing— Act , s 43D (1) (a)","content":"### sec.6 Documents and proof of identity required for supply of a controlled substance or controlled thing— Act , s 43D (1) (a)\n\nThis section applies to a person who supplies a controlled substance or controlled thing under a relevant transaction to anyone else (a recipient ).\nThe person must, before supplying the substance or thing, obtain from the recipient a document (an end user declaration ) showing the following information—\nthe recipient’s name and address, and if the recipient purports to obtain the substance or thing for another person, the other person’s name and address;\ndetails of the official document produced by the recipient under subsection (3) as evidence of the recipient’s identity;\nthe date and number of the written order for the supply of the substance or thing;\nthe name and quantity of the substance or thing to be supplied;\nif a thing is supplied—the serial number or unique identifier of the thing;\nthe date on which the substance or thing is to be supplied;\nthe purpose for which the substance or thing is to be supplied.\nIf the recipient is an individual, the person must, before supplying the substance or thing, require the recipient to produce an official document containing the recipient’s photograph (for example, a passport or driver licence) as evidence of the recipient’s identity.\nThe person must, immediately the person supplies the substance or thing under the transaction, make an invoice for the supply of the substance or thing showing the following details—\nthe recipient’s name and address;\nthe recipient’s order number for the supply of the substance or thing;\nthe date the substance or thing was supplied;\nthe name and quantity of the substance or thing supplied.\nMaximum penalty for subsection (4) —20 penalty units.\ns 6 prev s 6 amd 1996 SL No. 309 s 8\nom 2002 SL No. 255 s 4\npres s 6 (prev s 12) ins 1996 SL No. 309 s 12\nrenum 2002 SL No. 255 s 5 (2)\namd 2008 Act No. 4 s 35 ; 2009 SL No. 99 s 5\n(sec.6-ssec.1) This section applies to a person who supplies a controlled substance or controlled thing under a relevant transaction to anyone else (a recipient ).\n(sec.6-ssec.2) The person must, before supplying the substance or thing, obtain from the recipient a document (an end user declaration ) showing the following information— the recipient’s name and address, and if the recipient purports to obtain the substance or thing for another person, the other person’s name and address; details of the official document produced by the recipient under subsection (3) as evidence of the recipient’s identity; the date and number of the written order for the supply of the substance or thing; the name and quantity of the substance or thing to be supplied; if a thing is supplied—the serial number or unique identifier of the thing; the date on which the substance or thing is to be supplied; the purpose for which the substance or thing is to be supplied.\n(sec.6-ssec.3) If the recipient is an individual, the person must, before supplying the substance or thing, require the recipient to produce an official document containing the recipient’s photograph (for example, a passport or driver licence) as evidence of the recipient’s identity.\n(sec.6-ssec.4) The person must, immediately the person supplies the substance or thing under the transaction, make an invoice for the supply of the substance or thing showing the following details— the recipient’s name and address; the recipient’s order number for the supply of the substance or thing; the date the substance or thing was supplied; the name and quantity of the substance or thing supplied. Maximum penalty for subsection (4) —20 penalty units.\n- (a) the recipient’s name and address, and if the recipient purports to obtain the substance or thing for another person, the other person’s name and address;\n- (b) details of the official document produced by the recipient under subsection (3) as evidence of the recipient’s identity;\n- (c) the date and number of the written order for the supply of the substance or thing;\n- (d) the name and quantity of the substance or thing to be supplied;\n- (e) if a thing is supplied—the serial number or unique identifier of the thing;\n- (f) the date on which the substance or thing is to be supplied;\n- (g) the purpose for which the substance or thing is to be supplied.\n- (a) the recipient’s name and address;\n- (b) the recipient’s order number for the supply of the substance or thing;\n- (c) the date the substance or thing was supplied;\n- (d) the name and quantity of the substance or thing supplied.","sortOrder":8},{"sectionNumber":"sec.6A","sectionType":"section","heading":"End user declaration to be given to commissioner of police service— Act , s 43D (1) (d)","content":"### sec.6A End user declaration to be given to commissioner of police service— Act , s 43D (1) (d)\n\nThis section applies to a person who supplies a controlled substance or controlled thing under a relevant transaction to anyone else (the recipient ).\nThe person must, as soon as practicable after obtaining from the recipient the end user declaration mentioned in section 6 (2) , give a copy of the end user declaration to the commissioner of the police service.\ns 6A ins 2008 Act No. 4 s 36\n(sec.6A-ssec.1) This section applies to a person who supplies a controlled substance or controlled thing under a relevant transaction to anyone else (the recipient ).\n(sec.6A-ssec.2) The person must, as soon as practicable after obtaining from the recipient the end user declaration mentioned in section 6 (2) , give a copy of the end user declaration to the commissioner of the police service.","sortOrder":9},{"sectionNumber":"sec.7","sectionType":"section","heading":"Details about supply of controlled substance or controlled thing to be recorded in register","content":"### sec.7 Details about supply of controlled substance or controlled thing to be recorded in register\n\nThe following details about a relevant transaction for the supply of a controlled substance or controlled thing must be recorded in the register—\nthe name and address of the recipient and, if the recipient purports to obtain the substance or thing for another person, the other person’s name and address;\nthe recipient’s order number for the supply of the substance or thing;\nthe invoice number for the supply of the substance or thing;\nif the recipient is—\na company—its Australian Company Number; or\nan individual—the type of official document produced under section 6 (3) and the following details about the document—\nwho issued it;\nits serial number or other identifying number or mark;\nthe name and quantity of the substance or thing supplied;\nthe date the substance or thing was supplied;\nthe purpose for which the substance or thing was supplied.\nThe details must be recorded in the register as soon as practicable, but in no case later than 7 days, after the day the person supplied the substance or thing under the transaction.\nNothing in this section prevents the keeping of a single register for the Act and another Act if—\nthe keeping of the single register is not contrary to the other Act; and\nthe details recorded under subsection (1) are easily identifiable in the single register.\nSee section 43D (1) (c) of the Act for the requirement to keep the register.\ns 7 prev s 7 sub reg pubd gaz 17 December 1988 pp 2214–15\namd 1996 SL No. 309 s 9\nom 2002 SL No. 255 s 4\npres s 7 (prev s 13) ins 1996 SL No. 309 s 12\nrenum 2002 SL No. 255 s 5 (2)\namd 2008 Act No. 4 s 37 ; 2012 SL No. 92 s 19\n(sec.7-ssec.1) The following details about a relevant transaction for the supply of a controlled substance or controlled thing must be recorded in the register— the name and address of the recipient and, if the recipient purports to obtain the substance or thing for another person, the other person’s name and address; the recipient’s order number for the supply of the substance or thing; the invoice number for the supply of the substance or thing; if the recipient is— a company—its Australian Company Number; or an individual—the type of official document produced under section 6 (3) and the following details about the document— who issued it; its serial number or other identifying number or mark; the name and quantity of the substance or thing supplied; the date the substance or thing was supplied; the purpose for which the substance or thing was supplied.\n(sec.7-ssec.2) The details must be recorded in the register as soon as practicable, but in no case later than 7 days, after the day the person supplied the substance or thing under the transaction.\n(sec.7-ssec.3) Nothing in this section prevents the keeping of a single register for the Act and another Act if— the keeping of the single register is not contrary to the other Act; and the details recorded under subsection (1) are easily identifiable in the single register. See section 43D (1) (c) of the Act for the requirement to keep the register.\n- (a) the name and address of the recipient and, if the recipient purports to obtain the substance or thing for another person, the other person’s name and address;\n- (b) the recipient’s order number for the supply of the substance or thing;\n- (c) the invoice number for the supply of the substance or thing;\n- (d) if the recipient is— (i) a company—its Australian Company Number; or (ii) an individual—the type of official document produced under section 6 (3) and the following details about the document— (A) who issued it; (B) its serial number or other identifying number or mark;\n- (i) a company—its Australian Company Number; or\n- (ii) an individual—the type of official document produced under section 6 (3) and the following details about the document— (A) who issued it; (B) its serial number or other identifying number or mark;\n- (A) who issued it;\n- (B) its serial number or other identifying number or mark;\n- (e) the name and quantity of the substance or thing supplied;\n- (f) the date the substance or thing was supplied;\n- (g) the purpose for which the substance or thing was supplied.\n- (i) a company—its Australian Company Number; or\n- (ii) an individual—the type of official document produced under section 6 (3) and the following details about the document— (A) who issued it; (B) its serial number or other identifying number or mark;\n- (A) who issued it;\n- (B) its serial number or other identifying number or mark;\n- (A) who issued it;\n- (B) its serial number or other identifying number or mark;\n- (a) the keeping of the single register is not contrary to the other Act; and\n- (b) the details recorded under subsection (1) are easily identifiable in the single register.","sortOrder":10},{"sectionNumber":"sec.8","sectionType":"section","heading":"Details about loss or theft of controlled substance or controlled thing to be recorded in register","content":"### sec.8 Details about loss or theft of controlled substance or controlled thing to be recorded in register\n\nThe following details of the reporting to a police officer of the loss or theft of a controlled substance or controlled thing must be recorded in the register—\nthe day and place the report was made;\nthe name and registered number of the officer to whom the report was made;\nthe name and quantity of the substance or thing lost or stolen.\ns 8 prev s 8 om 1996 SL No. 309 s 10\npres s 8 (prev s 14) ins 1996 SL No. 309 s 12\nrenum 2002 SL No. 255 s 5 (2)\namd 2008 Act No. 4 s 38\n- (a) the day and place the report was made;\n- (b) the name and registered number of the officer to whom the report was made;\n- (c) the name and quantity of the substance or thing lost or stolen.","sortOrder":11},{"sectionNumber":"sec.9","sectionType":"section","heading":"Keeping of register, invoice and other documents","content":"### sec.9 Keeping of register, invoice and other documents\n\nThis section applies to the register and other documents mentioned in the Act , section 43D (1) and the invoice required under section 6 (4) .\nA person who supplies a controlled substance or controlled thing under a relevant transaction must keep the register, documents or invoice—\nat the principal or only place in Queensland where the person engages in relevant transactions; and\nfor 2 years from the day the person supplied the substance or thing under the transaction.\ns 9 (prev s 15) ins 1996 SL No. 309 s 12\nrenum 2002 SL No. 255 s 5 (2)\namd 2008 Act No. 4 s 39\n(sec.9-ssec.1) This section applies to the register and other documents mentioned in the Act , section 43D (1) and the invoice required under section 6 (4) .\n(sec.9-ssec.2) A person who supplies a controlled substance or controlled thing under a relevant transaction must keep the register, documents or invoice— at the principal or only place in Queensland where the person engages in relevant transactions; and for 2 years from the day the person supplied the substance or thing under the transaction.\n- (a) at the principal or only place in Queensland where the person engages in relevant transactions; and\n- (b) for 2 years from the day the person supplied the substance or thing under the transaction.","sortOrder":12},{"sectionNumber":"pt.4","sectionType":"part","heading":"Commercial production of industrial cannabis","content":"# Commercial production of industrial cannabis","sortOrder":13},{"sectionNumber":"pt.4-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":14},{"sectionNumber":"sec.10","sectionType":"section","heading":"Operation of pt 4 and schs 7 and 8","content":"### sec.10 Operation of pt 4 and schs 7 and 8\n\nDivisions 3 to 6 state activities stated persons are authorised to perform for the purposes of part 5B of the Act .\nSchedule 7 states conditions applying to particular persons who perform activities stated in divisions 4 , 5 and 6 .\nIf a word used in this part, schedule 7 or schedule 8 is not defined in the dictionary but is defined for part 5B of the Act , the word has the same meaning as in that part, unless a contrary intention appears.\nSee section 46 of the Act for definitions for pt 5B of the Act .\ns 10 ins 2002 SL No. 255 s 6\namd 2012 SL No. 92 s 20 ; 2018 Act No. 5 s 135\n(sec.10-ssec.1) Divisions 3 to 6 state activities stated persons are authorised to perform for the purposes of part 5B of the Act .\n(sec.10-ssec.2) Schedule 7 states conditions applying to particular persons who perform activities stated in divisions 4 , 5 and 6 .\n(sec.10-ssec.3) If a word used in this part, schedule 7 or schedule 8 is not defined in the dictionary but is defined for part 5B of the Act , the word has the same meaning as in that part, unless a contrary intention appears. See section 46 of the Act for definitions for pt 5B of the Act .","sortOrder":15},{"sectionNumber":"pt.4-div.2","sectionType":"division","heading":"Certified cannabis seed","content":"## Certified cannabis seed","sortOrder":16},{"sectionNumber":"sec.11","sectionType":"section","heading":"Planting seed— Act , s 46 , def planting seed","content":"### sec.11 Planting seed— Act , s 46 , def planting seed\n\nThis section states, for section 46 of the Act , definition planting seed , when cannabis seed is taken to have been harvested from a cannabis plant (a 0.5% THC plant ) with a THC concentration, in the plant’s leaves and flowering heads, of not more than 0.5%.\nCannabis seed originating in the State is taken to have been harvested from a 0.5% THC plant if—\nboth of the following apply—\nan authorised person, at the request of the licensee or on the authorised person’s own initiative, arranges for the THC concentration of a representative sample for the seed to be analysed;\nthe results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\nthe seed is labelled with the required particulars.\nSee section 27C for additional labelling requirements.\nAlso, cannabis seed originating in the State is taken to have been harvested from a 0.5% THC plant if—\nboth of the following apply—\nan authorised person, at the request of the licensee or on the authorised person’s own initiative, authorises another person in writing to arrange for the THC concentration of a representative sample for the seed to be analysed in a NATA accredited laboratory;\nthe results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\nthe seed is labelled with the required particulars.\nSee section 27C for additional labelling requirements.\nCannabis seed originating in another State, or another country, is taken to have been harvested from a 0.5% THC plant if the recipient licensee—\ntakes reasonable steps to confirm that—\na representative sample for the seed has undergone an analysis that is substantially equivalent to an analysis mentioned in subsection (3) (a) (i) ; and\nthe results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\nlabels the cannabis seed with the required particulars.\nSee section 27C for additional labelling requirements.\nIn this section—\nauthorised person means—\nan inspector; or\nanother person authorised by the chief executive for the purpose of this section.\nrepresentative sample , for cannabis seed, means a representative sample of cannabis leaves and flowering heads taken from the crop from which the seed was harvested.\ns 11 ins 2002 SL No. 255 s 6\nsub 2018 Act No. 5 s 136\n(sec.11-ssec.1) This section states, for section 46 of the Act , definition planting seed , when cannabis seed is taken to have been harvested from a cannabis plant (a 0.5% THC plant ) with a THC concentration, in the plant’s leaves and flowering heads, of not more than 0.5%.\n(sec.11-ssec.2) Cannabis seed originating in the State is taken to have been harvested from a 0.5% THC plant if— both of the following apply— an authorised person, at the request of the licensee or on the authorised person’s own initiative, arranges for the THC concentration of a representative sample for the seed to be analysed; the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and the seed is labelled with the required particulars. See section 27C for additional labelling requirements.\n(sec.11-ssec.3) Also, cannabis seed originating in the State is taken to have been harvested from a 0.5% THC plant if— both of the following apply— an authorised person, at the request of the licensee or on the authorised person’s own initiative, authorises another person in writing to arrange for the THC concentration of a representative sample for the seed to be analysed in a NATA accredited laboratory; the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and the seed is labelled with the required particulars. See section 27C for additional labelling requirements.\n(sec.11-ssec.4) Cannabis seed originating in another State, or another country, is taken to have been harvested from a 0.5% THC plant if the recipient licensee— takes reasonable steps to confirm that— a representative sample for the seed has undergone an analysis that is substantially equivalent to an analysis mentioned in subsection (3) (a) (i) ; and the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and labels the cannabis seed with the required particulars. See section 27C for additional labelling requirements.\n(sec.11-ssec.5) In this section— authorised person means— an inspector; or another person authorised by the chief executive for the purpose of this section. representative sample , for cannabis seed, means a representative sample of cannabis leaves and flowering heads taken from the crop from which the seed was harvested.\n- (a) both of the following apply— (i) an authorised person, at the request of the licensee or on the authorised person’s own initiative, arranges for the THC concentration of a representative sample for the seed to be analysed; (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (i) an authorised person, at the request of the licensee or on the authorised person’s own initiative, arranges for the THC concentration of a representative sample for the seed to be analysed;\n- (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (b) the seed is labelled with the required particulars. Note— See section 27C for additional labelling requirements.\n- (i) an authorised person, at the request of the licensee or on the authorised person’s own initiative, arranges for the THC concentration of a representative sample for the seed to be analysed;\n- (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (a) both of the following apply— (i) an authorised person, at the request of the licensee or on the authorised person’s own initiative, authorises another person in writing to arrange for the THC concentration of a representative sample for the seed to be analysed in a NATA accredited laboratory; (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (i) an authorised person, at the request of the licensee or on the authorised person’s own initiative, authorises another person in writing to arrange for the THC concentration of a representative sample for the seed to be analysed in a NATA accredited laboratory;\n- (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (b) the seed is labelled with the required particulars. Note— See section 27C for additional labelling requirements.\n- (i) an authorised person, at the request of the licensee or on the authorised person’s own initiative, authorises another person in writing to arrange for the THC concentration of a representative sample for the seed to be analysed in a NATA accredited laboratory;\n- (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (a) takes reasonable steps to confirm that— (i) a representative sample for the seed has undergone an analysis that is substantially equivalent to an analysis mentioned in subsection (3) (a) (i) ; and (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (i) a representative sample for the seed has undergone an analysis that is substantially equivalent to an analysis mentioned in subsection (3) (a) (i) ; and\n- (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (b) labels the cannabis seed with the required particulars. Note— See section 27C for additional labelling requirements.\n- (i) a representative sample for the seed has undergone an analysis that is substantially equivalent to an analysis mentioned in subsection (3) (a) (i) ; and\n- (ii) the results of the analysis state the THC concentration of the representative sample is not more than 0.5%; and\n- (a) an inspector; or\n- (b) another person authorised by the chief executive for the purpose of this section.","sortOrder":17},{"sectionNumber":"pt.4-div.3","sectionType":"division","heading":"Carriers","content":"## Carriers","sortOrder":18},{"sectionNumber":"sec.12","sectionType":"section","heading":"Application of div 3","content":"### sec.12 Application of div 3\n\nThis division applies to a carrier only if the carrier is engaged or employed by any of the following to transport consigned cannabis—\na researcher;\na grower;\na DPI researcher;\nan inspector;\na seed supplier.\ns 12 ins 2002 SL No. 255 s 6\namd 2018 Act No. 5 s 137\n- (a) a researcher;\n- (b) a grower;\n- (c) a DPI researcher;\n- (d) an inspector;\n- (e) a seed supplier.","sortOrder":19},{"sectionNumber":"sec.13","sectionType":"section","heading":"Supply","content":"### sec.13 Supply\n\nThe carrier is authorised to transport consigned cannabis and give it to the person to whom it is consigned.\nThe authorisation—\nis for the time necessary for the carrier to transport the consigned cannabis and give it to the person to whom it is consigned; and\nhas effect only while the carrier is acting in accordance with the terms of the carrier’s engagement or employment.\ns 13 ins 2002 SL No. 255 s 6\n(sec.13-ssec.1) The carrier is authorised to transport consigned cannabis and give it to the person to whom it is consigned.\n(sec.13-ssec.2) The authorisation— is for the time necessary for the carrier to transport the consigned cannabis and give it to the person to whom it is consigned; and has effect only while the carrier is acting in accordance with the terms of the carrier’s engagement or employment.\n- (a) is for the time necessary for the carrier to transport the consigned cannabis and give it to the person to whom it is consigned; and\n- (b) has effect only while the carrier is acting in accordance with the terms of the carrier’s engagement or employment.","sortOrder":20},{"sectionNumber":"sec.14","sectionType":"section","heading":"Possession","content":"### sec.14 Possession\n\nThe carrier is authorised to possess consigned cannabis for the time necessary for the carrier to transport it to the person to whom it is consigned and give it to the person.\nThe authorisation has effect only while the carrier is acting in accordance with the terms of the carrier’s engagement or employment.\ns 14 ins 2002 SL No. 255 s 6\n(sec.14-ssec.1) The carrier is authorised to possess consigned cannabis for the time necessary for the carrier to transport it to the person to whom it is consigned and give it to the person.\n(sec.14-ssec.2) The authorisation has effect only while the carrier is acting in accordance with the terms of the carrier’s engagement or employment.","sortOrder":21},{"sectionNumber":"pt.4-div.4","sectionType":"division","heading":"DPI researchers","content":"## DPI researchers","sortOrder":22},{"sectionNumber":"sec.15","sectionType":"section","heading":"Supply","content":"### sec.15 Supply\n\nA DPI researcher is authorised—\nto supply class A or class B research cannabis plants and seed to another DPI researcher or a researcher authorised to possess the cannabis plants and seed; and\nto supply class A and class B research cannabis seed to a grower for use, under the DPI researcher’s supervision, as part of a field trial the DPI researcher is conducting on land owned or leased by the grower; and\nto supply industrial cannabis seed to any of the following—\na grower;\na researcher;\nanother DPI researcher;\na seed handler;\nthe owner or operator of a facility where processed cannabis is, or is to be, used for manufacturing a manufactured product for sale by wholesale or retail; and\nto supply class A or class B research cannabis seed or industrial cannabis seed to a person in another State who is authorised under the law of that State to possess cannabis seed that, if grown, will produce plants with a THC concentration in their leaves and flowering heads that the person in the other State may possess; and\nto supply class A or class B research cannabis plants, industrial cannabis plants or processed cannabis to an analyst; and\nto supply processed cannabis to the owner or operator of a facility where processed cannabis is used for manufacturing a manufactured product for sale by wholesale or retail.\ns 15 ins 2002 SL No. 255 s 6\namd 2018 Act No. 5 s 138\n- (a) to supply class A or class B research cannabis plants and seed to another DPI researcher or a researcher authorised to possess the cannabis plants and seed; and\n- (b) to supply class A and class B research cannabis seed to a grower for use, under the DPI researcher’s supervision, as part of a field trial the DPI researcher is conducting on land owned or leased by the grower; and\n- (c) to supply industrial cannabis seed to any of the following— (i) a grower; (ii) a researcher; (iii) another DPI researcher; (iv) a seed handler; (v) the owner or operator of a facility where processed cannabis is, or is to be, used for manufacturing a manufactured product for sale by wholesale or retail; and\n- (i) a grower;\n- (ii) a researcher;\n- (iii) another DPI researcher;\n- (iv) a seed handler;\n- (v) the owner or operator of a facility where processed cannabis is, or is to be, used for manufacturing a manufactured product for sale by wholesale or retail; and\n- (d) to supply class A or class B research cannabis seed or industrial cannabis seed to a person in another State who is authorised under the law of that State to possess cannabis seed that, if grown, will produce plants with a THC concentration in their leaves and flowering heads that the person in the other State may possess; and\n- (e) to supply class A or class B research cannabis plants, industrial cannabis plants or processed cannabis to an analyst; and\n- (f) to supply processed cannabis to the owner or operator of a facility where processed cannabis is used for manufacturing a manufactured product for sale by wholesale or retail.\n- (i) a grower;\n- (ii) a researcher;\n- (iii) another DPI researcher;\n- (iv) a seed handler;\n- (v) the owner or operator of a facility where processed cannabis is, or is to be, used for manufacturing a manufactured product for sale by wholesale or retail; and","sortOrder":23},{"sectionNumber":"sec.16","sectionType":"section","heading":"Production","content":"### sec.16 Production\n\nA DPI researcher is authorised to produce, for use in plant breeding programs for developing new commercial strains of industrial cannabis—\nindustrial cannabis plants and seed; and\nclass A and class B research cannabis plants and seed.\ns 16 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\n- (a) industrial cannabis plants and seed; and\n- (b) class A and class B research cannabis plants and seed.","sortOrder":24},{"sectionNumber":"sec.17","sectionType":"section","heading":"Possession","content":"### sec.17 Possession\n\nA DPI researcher is authorised to possess any of the following for a purpose mentioned in section 15 or 16 —\nindustrial cannabis plants and seed;\nclass A and class B research cannabis plants and seed;\nprocessed cannabis.\ns 17 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\n- (a) industrial cannabis plants and seed;\n- (b) class A and class B research cannabis plants and seed;\n- (c) processed cannabis.","sortOrder":25},{"sectionNumber":"pt.4-div.5","sectionType":"division","heading":"Inspectors","content":"## Inspectors","sortOrder":26},{"sectionNumber":"sec.18","sectionType":"section","heading":"Supply","content":"### sec.18 Supply\n\nAn inspector is authorised—\nto supply industrial cannabis plants, class A or class B research cannabis plants or processed cannabis to an analyst to analyse the THC concentration in any of them; and\nif the inspector is given industrial cannabis plants or seed or class A or class B research cannabis plants or seed for delivery to a particular person who is lawfully entitled to possess the plants or seed—to supply the plants or seed to the person.\ns 18 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\n- (a) to supply industrial cannabis plants, class A or class B research cannabis plants or processed cannabis to an analyst to analyse the THC concentration in any of them; and\n- (b) if the inspector is given industrial cannabis plants or seed or class A or class B research cannabis plants or seed for delivery to a particular person who is lawfully entitled to possess the plants or seed—to supply the plants or seed to the person.","sortOrder":27},{"sectionNumber":"sec.19","sectionType":"section","heading":"Possession","content":"### sec.19 Possession\n\nAn inspector is authorised—\nto possess industrial cannabis plants, class A or class B research cannabis plants or processed cannabis given to the inspector for delivery to an analyst to analyse the THC concentration in the plants or processed cannabis; and\nto possess industrial cannabis plants or seed or class A or class B research cannabis plants or seed given to the inspector for delivery to a person lawfully entitled to possess the plants or seed.\ns 19 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\n- (a) to possess industrial cannabis plants, class A or class B research cannabis plants or processed cannabis given to the inspector for delivery to an analyst to analyse the THC concentration in the plants or processed cannabis; and\n- (b) to possess industrial cannabis plants or seed or class A or class B research cannabis plants or seed given to the inspector for delivery to a person lawfully entitled to possess the plants or seed.","sortOrder":28},{"sectionNumber":"pt.4-div.6","sectionType":"division","heading":"Other persons","content":"## Other persons","sortOrder":29},{"sectionNumber":"sec.20","sectionType":"section","heading":"Manufacturer","content":"### sec.20 Manufacturer\n\nThe owner or operator of a facility where processed cannabis is used for manufacturing a manufactured product for sale by wholesale or retail is authorised to possess processed cannabis for using it for manufacturing a manufactured product.\ns 20 prev s 20 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\nom 2018 Act No. 5 s 139\npres s 20 (prev s 23) ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\nrenum 2018 Act No. 5 s 149","sortOrder":30},{"sectionNumber":"sec.21","sectionType":"section","heading":"Analyst","content":"### sec.21 Analyst\n\nAn analyst is authorised to possess—\nstandard THC material to calibrate an analytical instrument used for analysing a substance to determine its THC concentration; and\nif an authorised person engages or employs the analyst to analyse a substance to determine its THC concentration—the substance for the purpose of the analysis.\nIn this section—\nauthorised person means any of the following—\na researcher;\na grower;\na DPI researcher;\nan inspector.\nsubstance means a substance that an authorised person reasonably believes to be any of the following—\nindustrial cannabis plants;\nclass A or class B research cannabis plants;\nprocessed cannabis.\ns 21 prev s 21 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\nom 2018 Act No. 5 s 139\npres s 21 (prev s 24) ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\namd 2018 Act No. 5 s 141\nrenum 2018 Act No. 5 s 149\n(sec.21-ssec.1) An analyst is authorised to possess— standard THC material to calibrate an analytical instrument used for analysing a substance to determine its THC concentration; and if an authorised person engages or employs the analyst to analyse a substance to determine its THC concentration—the substance for the purpose of the analysis.\n(sec.21-ssec.2) In this section— authorised person means any of the following— a researcher; a grower; a DPI researcher; an inspector. substance means a substance that an authorised person reasonably believes to be any of the following— industrial cannabis plants; class A or class B research cannabis plants; processed cannabis.\n- (a) standard THC material to calibrate an analytical instrument used for analysing a substance to determine its THC concentration; and\n- (b) if an authorised person engages or employs the analyst to analyse a substance to determine its THC concentration—the substance for the purpose of the analysis.\n- (a) a researcher;\n- (b) a grower;\n- (c) a DPI researcher;\n- (d) an inspector.\n- (a) industrial cannabis plants;\n- (b) class A or class B research cannabis plants;\n- (c) processed cannabis.","sortOrder":31},{"sectionNumber":"sec.22","sectionType":"section","heading":"Family members","content":"### sec.22 Family members\n\nA person who is a member of the immediate family of a licensee is authorised to produce, possess or supply a substance if—\nthe licensee is authorised to produce, possess or supply the substance under the Act ; and\nthe person’s production, possession or supply of the substance is necessary for, or incidental to the licensee’s production, possession or supply of the substance.\nIn this section—\nsubstance means any of the following—\nclass A research cannabis plants;\nclass A research cannabis seed;\nclass B research cannabis plants;\nclass B research cannabis seed;\nindustrial cannabis plants;\nindustrial cannabis seed;\nprocessed cannabis.\ns 22 prev s 22 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\nom 2018 Act No. 5 s 140\npres s 22 (prev s 25) ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\nrenum 2018 Act No. 5 s 149\n(sec.22-ssec.1) A person who is a member of the immediate family of a licensee is authorised to produce, possess or supply a substance if— the licensee is authorised to produce, possess or supply the substance under the Act ; and the person’s production, possession or supply of the substance is necessary for, or incidental to the licensee’s production, possession or supply of the substance.\n(sec.22-ssec.2) In this section— substance means any of the following— class A research cannabis plants; class A research cannabis seed; class B research cannabis plants; class B research cannabis seed; industrial cannabis plants; industrial cannabis seed; processed cannabis.\n- (a) the licensee is authorised to produce, possess or supply the substance under the Act ; and\n- (b) the person’s production, possession or supply of the substance is necessary for, or incidental to the licensee’s production, possession or supply of the substance.\n- (a) class A research cannabis plants;\n- (b) class A research cannabis seed;\n- (c) class B research cannabis plants;\n- (d) class B research cannabis seed;\n- (e) industrial cannabis plants;\n- (f) industrial cannabis seed;\n- (g) processed cannabis.","sortOrder":32},{"sectionNumber":"sec.23","sectionType":"section","heading":"Employees of authorised persons","content":"### sec.23 Employees of authorised persons\n\nAn employee of an authorised person is authorised to produce, possess, supply or transport a substance if—\nunder the Act , the authorised person is authorised to produce, possess, supply or transport the substance; and\nthe employee’s production, possession, supply or transportation of the substance is necessary for, or incidental to, performing the employee’s employment or engagement.\nIn this section—\nauthorised person means any of the following—\na licensee;\na carrier;\na DPI researcher;\nan inspector;\na manufacturer;\nan analyst.\nemployee includes agent.\nsubstance means any of the following—\nclass A research cannabis plant;\nclass A research cannabis seed;\nclass B research cannabis plant;\nclass B research cannabis seed;\nindustrial cannabis plant;\nindustrial cannabis seed;\nprocessed cannabis.\ns 23 (prev s 26) ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\namd 2018 Act No. 5 s 142\nrenum 2018 Act No. 5 s 149\n(sec.23-ssec.1) An employee of an authorised person is authorised to produce, possess, supply or transport a substance if— under the Act , the authorised person is authorised to produce, possess, supply or transport the substance; and the employee’s production, possession, supply or transportation of the substance is necessary for, or incidental to, performing the employee’s employment or engagement.\n(sec.23-ssec.2) In this section— authorised person means any of the following— a licensee; a carrier; a DPI researcher; an inspector; a manufacturer; an analyst. employee includes agent. substance means any of the following— class A research cannabis plant; class A research cannabis seed; class B research cannabis plant; class B research cannabis seed; industrial cannabis plant; industrial cannabis seed; processed cannabis.\n- (a) under the Act , the authorised person is authorised to produce, possess, supply or transport the substance; and\n- (b) the employee’s production, possession, supply or transportation of the substance is necessary for, or incidental to, performing the employee’s employment or engagement.\n- (a) a licensee;\n- (b) a carrier;\n- (c) a DPI researcher;\n- (d) an inspector;\n- (e) a manufacturer;\n- (f) an analyst.\n- (a) class A research cannabis plant;\n- (b) class A research cannabis seed;\n- (c) class B research cannabis plant;\n- (d) class B research cannabis seed;\n- (e) industrial cannabis plant;\n- (f) industrial cannabis seed;\n- (g) processed cannabis.","sortOrder":33},{"sectionNumber":"pt.4-div.7","sectionType":"division","heading":"Record requirements","content":"## Record requirements","sortOrder":34},{"sectionNumber":"sec.24","sectionType":"section","heading":"Record requirements— Act , s 110E","content":"### sec.24 Record requirements— Act , s 110E\n\nThis division prescribes, for section 110E of the Act , record requirements for the holder of a relevant authority.\ns 24 (prev s 26A) ins 2018 Act No. 5 s 132\nrenum 2018 Act No. 5 s 149","sortOrder":35},{"sectionNumber":"sec.25","sectionType":"section","heading":"Recording information—researchers and growers","content":"### sec.25 Recording information—researchers and growers\n\nA licensee, who is a researcher or a grower, must make a written record of each of the following—\nthe strains or varieties of all cannabis seed in the licensee’s possession;\nthe strains or varieties of all cannabis plants the licensee is growing;\nthe source and quantity of all cannabis plants and seed supplied to the licensee;\nif the licensee is the first licensee to take possession of planting seed after the seed enters the State—a report number, or other identifying information, for the report containing the results mentioned in section 11 (4) (a) (ii) ;\nwhen and by whom cannabis plants or seed were delivered to the licensee;\nif cannabis plants or seed is delivered to the licensee by a carrier—the name of the individual who actually delivered the plants or seed;\nif the licensee supplies cannabis plants or seed to a carrier for delivery to a person—\nthe name of the individual to whom the plants or seed were given for delivery; and\nthe name of the person to whom it is intended the plants or seed be supplied by the licensee;\nwhen cannabis seed is planted by the licensee;\nif the licensee supplies cannabis plants or seed to another person (the recipient ) who is authorised to possess the cannabis plants or seed—\nthe name of the recipient; and\nwhat the recipient intends to use the cannabis plants or seed for; and\nfor cannabis plants or seed that is not processed cannabis—particulars of how the cannabis plants or seed was grown, or otherwise obtained, by the licensee; and\nthe date on which the cannabis plants or seed was supplied to the recipient; and\nthe quantity of cannabis plants or seed supplied to the recipient;\nif the licensee disposes of or destroys cannabis plants or seed—\nthe date the cannabis plants or seed is disposed of or destroyed; and\nthe method the licensee used to dispose of or destroy the cannabis plants or seed.\nThe licensee must make the record of the information as soon as practicable, but no later than 7 days, after the information becomes available to the licensee.\ns 25 (prev s 26B) ins 2018 Act No. 5 s 132\namd 2018 Act No. 5 s 143\nrenum 2018 Act No. 5 s 149\n(sec.25-ssec.1) A licensee, who is a researcher or a grower, must make a written record of each of the following— the strains or varieties of all cannabis seed in the licensee’s possession; the strains or varieties of all cannabis plants the licensee is growing; the source and quantity of all cannabis plants and seed supplied to the licensee; if the licensee is the first licensee to take possession of planting seed after the seed enters the State—a report number, or other identifying information, for the report containing the results mentioned in section 11 (4) (a) (ii) ; when and by whom cannabis plants or seed were delivered to the licensee; if cannabis plants or seed is delivered to the licensee by a carrier—the name of the individual who actually delivered the plants or seed; if the licensee supplies cannabis plants or seed to a carrier for delivery to a person— the name of the individual to whom the plants or seed were given for delivery; and the name of the person to whom it is intended the plants or seed be supplied by the licensee; when cannabis seed is planted by the licensee; if the licensee supplies cannabis plants or seed to another person (the recipient ) who is authorised to possess the cannabis plants or seed— the name of the recipient; and what the recipient intends to use the cannabis plants or seed for; and for cannabis plants or seed that is not processed cannabis—particulars of how the cannabis plants or seed was grown, or otherwise obtained, by the licensee; and the date on which the cannabis plants or seed was supplied to the recipient; and the quantity of cannabis plants or seed supplied to the recipient; if the licensee disposes of or destroys cannabis plants or seed— the date the cannabis plants or seed is disposed of or destroyed; and the method the licensee used to dispose of or destroy the cannabis plants or seed.\n(sec.25-ssec.2) The licensee must make the record of the information as soon as practicable, but no later than 7 days, after the information becomes available to the licensee.\n- (a) the strains or varieties of all cannabis seed in the licensee’s possession;\n- (b) the strains or varieties of all cannabis plants the licensee is growing;\n- (c) the source and quantity of all cannabis plants and seed supplied to the licensee;\n- (d) if the licensee is the first licensee to take possession of planting seed after the seed enters the State—a report number, or other identifying information, for the report containing the results mentioned in section 11 (4) (a) (ii) ;\n- (e) when and by whom cannabis plants or seed were delivered to the licensee;\n- (f) if cannabis plants or seed is delivered to the licensee by a carrier—the name of the individual who actually delivered the plants or seed;\n- (g) if the licensee supplies cannabis plants or seed to a carrier for delivery to a person— (i) the name of the individual to whom the plants or seed were given for delivery; and (ii) the name of the person to whom it is intended the plants or seed be supplied by the licensee;\n- (i) the name of the individual to whom the plants or seed were given for delivery; and\n- (ii) the name of the person to whom it is intended the plants or seed be supplied by the licensee;\n- (h) when cannabis seed is planted by the licensee;\n- (i) if the licensee supplies cannabis plants or seed to another person (the recipient ) who is authorised to possess the cannabis plants or seed— (i) the name of the recipient; and (ii) what the recipient intends to use the cannabis plants or seed for; and (iii) for cannabis plants or seed that is not processed cannabis—particulars of how the cannabis plants or seed was grown, or otherwise obtained, by the licensee; and (iv) the date on which the cannabis plants or seed was supplied to the recipient; and (v) the quantity of cannabis plants or seed supplied to the recipient;\n- (i) the name of the recipient; and\n- (ii) what the recipient intends to use the cannabis plants or seed for; and\n- (iii) for cannabis plants or seed that is not processed cannabis—particulars of how the cannabis plants or seed was grown, or otherwise obtained, by the licensee; and\n- (iv) the date on which the cannabis plants or seed was supplied to the recipient; and\n- (v) the quantity of cannabis plants or seed supplied to the recipient;\n- (j) if the licensee disposes of or destroys cannabis plants or seed— (i) the date the cannabis plants or seed is disposed of or destroyed; and (ii) the method the licensee used to dispose of or destroy the cannabis plants or seed.\n- (i) the date the cannabis plants or seed is disposed of or destroyed; and\n- (ii) the method the licensee used to dispose of or destroy the cannabis plants or seed.\n- (i) the name of the individual to whom the plants or seed were given for delivery; and\n- (ii) the name of the person to whom it is intended the plants or seed be supplied by the licensee;\n- (i) the name of the recipient; and\n- (ii) what the recipient intends to use the cannabis plants or seed for; and\n- (iii) for cannabis plants or seed that is not processed cannabis—particulars of how the cannabis plants or seed was grown, or otherwise obtained, by the licensee; and\n- (iv) the date on which the cannabis plants or seed was supplied to the recipient; and\n- (v) the quantity of cannabis plants or seed supplied to the recipient;\n- (i) the date the cannabis plants or seed is disposed of or destroyed; and\n- (ii) the method the licensee used to dispose of or destroy the cannabis plants or seed.","sortOrder":36},{"sectionNumber":"sec.26","sectionType":"section","heading":"Recording information—seed handlers","content":"### sec.26 Recording information—seed handlers\n\nA seed handler must make a written record of each of the following—\nthe source and quantity of all industrial cannabis seed supplied to the seed handler;\nwhen and by whom industrial cannabis seed was delivered to the seed handler;\nif industrial cannabis seed is delivered to the seed handler by a carrier—the name of the individual who actually delivered the seed;\nif the seed handler is the first licensee to take possession of planting seed after the seed enters the State—a report number, or other identifying information, for the report containing the results mentioned in section 11 (4) (a) (ii) ;\nif the industrial cannabis is denatured by the seed handler—how, when and by whom the industrial cannabis seed was denatured;\nif the seed handler supplies industrial cannabis seed to a carrier for delivery to a person—\nthe name of the person to whom the seed was given for delivery; and\nthe name of the person to whom it is intended the seed be supplied by the seed handler;\nthe name of each person to whom the seed handler supplies industrial cannabis seed.\nThe seed handler must make the record of the information as soon as practicable, but no later than 7 days, after the information becomes available to the seed handler.\ns 26 (prev s 26C) ins 2018 Act No. 5 s 132\namd 2018 Act No. 5 s 144\nrenum 2018 Act No. 5 s 149\n(sec.26-ssec.1) A seed handler must make a written record of each of the following— the source and quantity of all industrial cannabis seed supplied to the seed handler; when and by whom industrial cannabis seed was delivered to the seed handler; if industrial cannabis seed is delivered to the seed handler by a carrier—the name of the individual who actually delivered the seed; if the seed handler is the first licensee to take possession of planting seed after the seed enters the State—a report number, or other identifying information, for the report containing the results mentioned in section 11 (4) (a) (ii) ; if the industrial cannabis is denatured by the seed handler—how, when and by whom the industrial cannabis seed was denatured; if the seed handler supplies industrial cannabis seed to a carrier for delivery to a person— the name of the person to whom the seed was given for delivery; and the name of the person to whom it is intended the seed be supplied by the seed handler; the name of each person to whom the seed handler supplies industrial cannabis seed.\n(sec.26-ssec.2) The seed handler must make the record of the information as soon as practicable, but no later than 7 days, after the information becomes available to the seed handler.\n- (a) the source and quantity of all industrial cannabis seed supplied to the seed handler;\n- (b) when and by whom industrial cannabis seed was delivered to the seed handler;\n- (c) if industrial cannabis seed is delivered to the seed handler by a carrier—the name of the individual who actually delivered the seed;\n- (d) if the seed handler is the first licensee to take possession of planting seed after the seed enters the State—a report number, or other identifying information, for the report containing the results mentioned in section 11 (4) (a) (ii) ;\n- (e) if the industrial cannabis is denatured by the seed handler—how, when and by whom the industrial cannabis seed was denatured;\n- (f) if the seed handler supplies industrial cannabis seed to a carrier for delivery to a person— (i) the name of the person to whom the seed was given for delivery; and (ii) the name of the person to whom it is intended the seed be supplied by the seed handler;\n- (i) the name of the person to whom the seed was given for delivery; and\n- (ii) the name of the person to whom it is intended the seed be supplied by the seed handler;\n- (g) the name of each person to whom the seed handler supplies industrial cannabis seed.\n- (i) the name of the person to whom the seed was given for delivery; and\n- (ii) the name of the person to whom it is intended the seed be supplied by the seed handler;","sortOrder":37},{"sectionNumber":"sec.26D","sectionType":"section","heading":null,"content":"### Section sec.26D\n\ns 26D ins 2018 Act No. 5 s 132\nom 2018 Act No. 5 s 145","sortOrder":38},{"sectionNumber":"sec.27","sectionType":"section","heading":"Keeping record of information","content":"### sec.27 Keeping record of information\n\nA holder of a relevant authority must keep the record of the information until the end of the first of the following periods—\nif the authority ends—3 years after the authority ends;\nif the holder stops being the holder of the authority—2 years after the holder stops being the holder of the authority.\nThe holder must keep the record in a form that is readily accessible, usable and able to be interpreted.\ns 27 prev s 27 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\nom 2018 Act No. 5 s 148\npres s 27 (prev s 26E) ins 2018 Act No. 5 s 132\nrenum 2018 Act No. 5 s 149\n(sec.27-ssec.1) A holder of a relevant authority must keep the record of the information until the end of the first of the following periods— if the authority ends—3 years after the authority ends; if the holder stops being the holder of the authority—2 years after the holder stops being the holder of the authority.\n(sec.27-ssec.2) The holder must keep the record in a form that is readily accessible, usable and able to be interpreted.\n- (a) if the authority ends—3 years after the authority ends;\n- (b) if the holder stops being the holder of the authority—2 years after the holder stops being the holder of the authority.","sortOrder":39},{"sectionNumber":"pt.4-div.7A","sectionType":"division","heading":"Notification requirements","content":"## Notification requirements","sortOrder":40},{"sectionNumber":"sec.27A","sectionType":"section","heading":"Notification requirements—researchers and growers","content":"### sec.27A Notification requirements—researchers and growers\n\nThis section prescribes, for section 110F of the Act , notification requirements for a licensee who is a researcher or a grower.\nThe licensee must give an inspector written notice—\nof the planting of cannabis seed by the licensee; and\nif cannabis plants planted by the licensee will not be harvested—of the following—\nthe plants will not be harvested;\nhow the licensee will dispose of or destroy the plants; and\nin relation to a crop of industrial cannabis or class B research cannabis plants planted by the licensee—that the crop is ready to be tested for THC concentration.\nThe licensee must give a notice under this section to an inspector—\nfor a notice mentioned in subsection (2) (a) —within 14 days of the planting of the seed; or\nfor a notice mentioned in subsection (2) (b) —within 3 months of the planting of the cannabis plants; or\nfor a notice mentioned in subsection (2) (c) —at least 4 weeks before the licensee intends to harvest the crop.\ns 27A (prev s 26F) ins 2018 Act No. 5 s 132\namd 2018 Act No. 5 s 146\nrenum 2018 Act No. 5 s 149\n(sec.27A-ssec.1) This section prescribes, for section 110F of the Act , notification requirements for a licensee who is a researcher or a grower.\n(sec.27A-ssec.2) The licensee must give an inspector written notice— of the planting of cannabis seed by the licensee; and if cannabis plants planted by the licensee will not be harvested—of the following— the plants will not be harvested; how the licensee will dispose of or destroy the plants; and in relation to a crop of industrial cannabis or class B research cannabis plants planted by the licensee—that the crop is ready to be tested for THC concentration.\n(sec.27A-ssec.3) The licensee must give a notice under this section to an inspector— for a notice mentioned in subsection (2) (a) —within 14 days of the planting of the seed; or for a notice mentioned in subsection (2) (b) —within 3 months of the planting of the cannabis plants; or for a notice mentioned in subsection (2) (c) —at least 4 weeks before the licensee intends to harvest the crop.\n- (a) of the planting of cannabis seed by the licensee; and\n- (b) if cannabis plants planted by the licensee will not be harvested—of the following— (i) the plants will not be harvested; (ii) how the licensee will dispose of or destroy the plants; and\n- (i) the plants will not be harvested;\n- (ii) how the licensee will dispose of or destroy the plants; and\n- (c) in relation to a crop of industrial cannabis or class B research cannabis plants planted by the licensee—that the crop is ready to be tested for THC concentration.\n- (i) the plants will not be harvested;\n- (ii) how the licensee will dispose of or destroy the plants; and\n- (a) for a notice mentioned in subsection (2) (a) —within 14 days of the planting of the seed; or\n- (b) for a notice mentioned in subsection (2) (b) —within 3 months of the planting of the cannabis plants; or\n- (c) for a notice mentioned in subsection (2) (c) —at least 4 weeks before the licensee intends to harvest the crop.","sortOrder":41},{"sectionNumber":"pt.4-div.8","sectionType":"division","heading":"Other provisions","content":"## Other provisions","sortOrder":42},{"sectionNumber":"sec.27B","sectionType":"section","heading":"Prescribed information for research plans— Act , s 54","content":"### sec.27B Prescribed information for research plans— Act , s 54\n\nThis section prescribes, for section 54 (2) (d) of the Act , information that must be included in a research plan relating to an application for a researcher licence.\nThe research plan must—\ndescribe the research and associated activities proposed to be carried out under the licence; and\ndescribe the location of all places where the research and associated activities will be carried out; and\nidentify any risk of non-compliance with the Act that is associated with the research and associated activities; and\ndescribe measures proposed to be implemented to manage all risks mentioned in paragraph (c) , including, for example—\nhow the following will be secured—\ncannabis crops, cannabis seed and equipment associated with the research and associated activities;\ninformation and records associated with the research and associated activities; and\nwhat security screening protocols will be put in place for the employees, or other persons, dealing with cannabis crops, cannabis seed and equipment associated with the research and associated activities; and\nhow the researcher will restrict access, of employees or other persons, to cannabis crops, cannabis seed and equipment associated with the research and associated activities; and\nhow cannabis crops, cannabis seed and equipment associated with the research and associated activities will be safely and securely stored, handled or transported; and\ncontain any additional information stated in a guideline published by the chief executive under subsection (3) .\nFor subsection (2) (e) , the chief executive may publish, on the department’s website, a guideline stating additional information that the chief executive reasonably considers is relevant for the management of risks associated with research and associated activities carried out under a researcher licence.\ns 27B ins 2018 Act No. 5 s 150\n(sec.27B-ssec.1) This section prescribes, for section 54 (2) (d) of the Act , information that must be included in a research plan relating to an application for a researcher licence.\n(sec.27B-ssec.2) The research plan must— describe the research and associated activities proposed to be carried out under the licence; and describe the location of all places where the research and associated activities will be carried out; and identify any risk of non-compliance with the Act that is associated with the research and associated activities; and describe measures proposed to be implemented to manage all risks mentioned in paragraph (c) , including, for example— how the following will be secured— cannabis crops, cannabis seed and equipment associated with the research and associated activities; information and records associated with the research and associated activities; and what security screening protocols will be put in place for the employees, or other persons, dealing with cannabis crops, cannabis seed and equipment associated with the research and associated activities; and how the researcher will restrict access, of employees or other persons, to cannabis crops, cannabis seed and equipment associated with the research and associated activities; and how cannabis crops, cannabis seed and equipment associated with the research and associated activities will be safely and securely stored, handled or transported; and contain any additional information stated in a guideline published by the chief executive under subsection (3) .\n(sec.27B-ssec.3) For subsection (2) (e) , the chief executive may publish, on the department’s website, a guideline stating additional information that the chief executive reasonably considers is relevant for the management of risks associated with research and associated activities carried out under a researcher licence.\n- (a) describe the research and associated activities proposed to be carried out under the licence; and\n- (b) describe the location of all places where the research and associated activities will be carried out; and\n- (c) identify any risk of non-compliance with the Act that is associated with the research and associated activities; and\n- (d) describe measures proposed to be implemented to manage all risks mentioned in paragraph (c) , including, for example— (i) how the following will be secured— (A) cannabis crops, cannabis seed and equipment associated with the research and associated activities; (B) information and records associated with the research and associated activities; and (ii) what security screening protocols will be put in place for the employees, or other persons, dealing with cannabis crops, cannabis seed and equipment associated with the research and associated activities; and (iii) how the researcher will restrict access, of employees or other persons, to cannabis crops, cannabis seed and equipment associated with the research and associated activities; and (iv) how cannabis crops, cannabis seed and equipment associated with the research and associated activities will be safely and securely stored, handled or transported; and\n- (i) how the following will be secured— (A) cannabis crops, cannabis seed and equipment associated with the research and associated activities; (B) information and records associated with the research and associated activities; and\n- (A) cannabis crops, cannabis seed and equipment associated with the research and associated activities;\n- (B) information and records associated with the research and associated activities; and\n- (ii) what security screening protocols will be put in place for the employees, or other persons, dealing with cannabis crops, cannabis seed and equipment associated with the research and associated activities; and\n- (iii) how the researcher will restrict access, of employees or other persons, to cannabis crops, cannabis seed and equipment associated with the research and associated activities; and\n- (iv) how cannabis crops, cannabis seed and equipment associated with the research and associated activities will be safely and securely stored, handled or transported; and\n- (e) contain any additional information stated in a guideline published by the chief executive under subsection (3) .\n- (i) how the following will be secured— (A) cannabis crops, cannabis seed and equipment associated with the research and associated activities; (B) information and records associated with the research and associated activities; and\n- (A) cannabis crops, cannabis seed and equipment associated with the research and associated activities;\n- (B) information and records associated with the research and associated activities; and\n- (ii) what security screening protocols will be put in place for the employees, or other persons, dealing with cannabis crops, cannabis seed and equipment associated with the research and associated activities; and\n- (iii) how the researcher will restrict access, of employees or other persons, to cannabis crops, cannabis seed and equipment associated with the research and associated activities; and\n- (iv) how cannabis crops, cannabis seed and equipment associated with the research and associated activities will be safely and securely stored, handled or transported; and\n- (A) cannabis crops, cannabis seed and equipment associated with the research and associated activities;\n- (B) information and records associated with the research and associated activities; and","sortOrder":43},{"sectionNumber":"sec.27C","sectionType":"section","heading":"Labelling method","content":"### sec.27C Labelling method\n\nThis section applies if a provision of this part, or a condition of a licence, requires—\ncannabis seed to be labelled so as to indicate particular information; or\nparticular information to otherwise be included on a container, however described, of cannabis seed.\nThe requirement is complied with only if the information is—\neither—\nwritten or stamped on—\nthe outside of the container in a position where the information can be clearly seen on the container; or\na label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or\nif, because the seed is being supplied in bulk, subparagraph (i) cannot reasonably be complied with—included in a written notice given to a person to whom the seed is supplied before or when the seed is delivered to the person; and\nwritten in English; and\nwritten in characters that are at least 1.5mm high; and\nwritten in characters that are either—\ndark print on a light background; or\nlight print on dark background.\nA notice under subsection (2) (a) (ii) may be fixed to, or form part of, a delivery docket or invoice given to the person to whom the seed is supplied.\ns 27C ins 2018 Act No. 5 s 150\n(sec.27C-ssec.1) This section applies if a provision of this part, or a condition of a licence, requires— cannabis seed to be labelled so as to indicate particular information; or particular information to otherwise be included on a container, however described, of cannabis seed.\n(sec.27C-ssec.2) The requirement is complied with only if the information is— either— written or stamped on— the outside of the container in a position where the information can be clearly seen on the container; or a label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or if, because the seed is being supplied in bulk, subparagraph (i) cannot reasonably be complied with—included in a written notice given to a person to whom the seed is supplied before or when the seed is delivered to the person; and written in English; and written in characters that are at least 1.5mm high; and written in characters that are either— dark print on a light background; or light print on dark background.\n(sec.27C-ssec.3) A notice under subsection (2) (a) (ii) may be fixed to, or form part of, a delivery docket or invoice given to the person to whom the seed is supplied.\n- (a) cannabis seed to be labelled so as to indicate particular information; or\n- (b) particular information to otherwise be included on a container, however described, of cannabis seed.\n- (a) either— (i) written or stamped on— (A) the outside of the container in a position where the information can be clearly seen on the container; or (B) a label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or (ii) if, because the seed is being supplied in bulk, subparagraph (i) cannot reasonably be complied with—included in a written notice given to a person to whom the seed is supplied before or when the seed is delivered to the person; and\n- (i) written or stamped on— (A) the outside of the container in a position where the information can be clearly seen on the container; or (B) a label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or\n- (A) the outside of the container in a position where the information can be clearly seen on the container; or\n- (B) a label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or\n- (ii) if, because the seed is being supplied in bulk, subparagraph (i) cannot reasonably be complied with—included in a written notice given to a person to whom the seed is supplied before or when the seed is delivered to the person; and\n- (b) written in English; and\n- (c) written in characters that are at least 1.5mm high; and\n- (d) written in characters that are either— (i) dark print on a light background; or (ii) light print on dark background.\n- (i) dark print on a light background; or\n- (ii) light print on dark background.\n- (i) written or stamped on— (A) the outside of the container in a position where the information can be clearly seen on the container; or (B) a label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or\n- (A) the outside of the container in a position where the information can be clearly seen on the container; or\n- (B) a label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or\n- (ii) if, because the seed is being supplied in bulk, subparagraph (i) cannot reasonably be complied with—included in a written notice given to a person to whom the seed is supplied before or when the seed is delivered to the person; and\n- (A) the outside of the container in a position where the information can be clearly seen on the container; or\n- (B) a label that is fixed to the outside of the container in a position where the label can be clearly seen on the container; or\n- (i) dark print on a light background; or\n- (ii) light print on dark background.","sortOrder":44},{"sectionNumber":"sec.28","sectionType":"section","heading":"Fees","content":"### sec.28 Fees\n\nThe fees payable under the Act are stated in section 28A and schedule 8E .\ns 28 ins 1998 SL No. 348 s 4\nsub 2002 SL No. 255 s 6\namd 2004 SL No. 231 s 14 ; 2005 SL No. 268 s 14 ; 2006 SL No. 267 s 14 ; 2007 SL No. 232 s 14 ; 2008 SL No. 314 s 14 ; 2009 SL No. 176 s 17 ; 2010 SL No. 268 s 7 ; 2011 SL No. 110 s 14 ; 2012 SL No. 92 s 21 ; 2013 SL No. 102 s 16 ; 2014 SL No. 113 s 16 ; 2015 SL No. 57 s 16 ; 2016 SL No. 99 s 14 ; 2017 SL No. 111 s 16 ; 2018 SL No. 98 s 16 ; 2019 SL No. 127 s 17\nsub 2020 SL No. 152 s 15 ; 2021 SL No. 85 s 16 ; 2022 SL No. 6 s 3","sortOrder":45},{"sectionNumber":"sec.28A","sectionType":"section","heading":"Monitoring fees— Act , s 110G","content":"### sec.28A Monitoring fees— Act , s 110G\n\nFor section 110G (1) of the Act , the monitoring fee for the monitoring of activities performed under a relevant authority is provided for in this section and schedule 8E , item 8.\nThe fee stated in schedule 8E , item 8 may consist of, or include, an amount for part of an hour that is the equivalent of the relevant proportion of the hourly rate, stated in the schedule, worked out using 15-minute periods (wholly or partly completed).\nIn addition to the monitoring fee stated in schedule 8E , item 8, the holder of the relevant authority must pay—\nthe fee worked out under subsection (4) for an inspector monitoring the activities to travel between the inspector’s usual place of work and the place where the activities are monitored; and\nif, for monitoring the activities, an inspector takes a sample of cannabis for analysis to determine the THC concentration of the sample—the reasonable cost of analysing the sample.\nFor subsection (3) (a) , the fee must be worked out at the rate stated in schedule 8E , item 8 for the time taken for the travel up to a maximum of 2 hours in a day.\ns 28A ins 2022 SL No. 6 s 3\namd 2022 SL No. 52 s 16\n(sec.28A-ssec.1) For section 110G (1) of the Act , the monitoring fee for the monitoring of activities performed under a relevant authority is provided for in this section and schedule 8E , item 8.\n(sec.28A-ssec.2) The fee stated in schedule 8E , item 8 may consist of, or include, an amount for part of an hour that is the equivalent of the relevant proportion of the hourly rate, stated in the schedule, worked out using 15-minute periods (wholly or partly completed).\n(sec.28A-ssec.3) In addition to the monitoring fee stated in schedule 8E , item 8, the holder of the relevant authority must pay— the fee worked out under subsection (4) for an inspector monitoring the activities to travel between the inspector’s usual place of work and the place where the activities are monitored; and if, for monitoring the activities, an inspector takes a sample of cannabis for analysis to determine the THC concentration of the sample—the reasonable cost of analysing the sample.\n(sec.28A-ssec.4) For subsection (3) (a) , the fee must be worked out at the rate stated in schedule 8E , item 8 for the time taken for the travel up to a maximum of 2 hours in a day.\n- (a) the fee worked out under subsection (4) for an inspector monitoring the activities to travel between the inspector’s usual place of work and the place where the activities are monitored; and\n- (b) if, for monitoring the activities, an inspector takes a sample of cannabis for analysis to determine the THC concentration of the sample—the reasonable cost of analysing the sample.","sortOrder":46},{"sectionNumber":"sec.29","sectionType":"section","heading":"Licence conditions— Act , s 64","content":"### sec.29 Licence conditions— Act , s 64\n\nThe conditions in schedule 8 are prescribed for section 64 (3) of the Act .\nUnless otherwise expressly stated, the conditions apply to all licensees.\ns 29 ins 2001 SL No. 52 s 3\nsub 2002 SL No. 255 s 6\n(sec.29-ssec.1) The conditions in schedule 8 are prescribed for section 64 (3) of the Act .\n(sec.29-ssec.2) Unless otherwise expressly stated, the conditions apply to all licensees.","sortOrder":47},{"sectionNumber":"pt.5","sectionType":"part","heading":"Transitional provisions","content":"# Transitional provisions","sortOrder":48},{"sectionNumber":"sec.30","sectionType":"section","heading":"Transitional provision for Drugs Misuse Amendment Regulation (No. 2) 2001","content":"### sec.30 Transitional provision for Drugs Misuse Amendment Regulation (No. 2) 2001\n\nTo remove doubt, it is declared that this regulation, as in force immediately before the commencement of the Drugs Misuse Amendment Regulation (No. 2) 2001 (the amending regulation ), continues to apply in relation to an offence against the Act committed before the commencement of the amending regulation.\nProceedings for an offence against the Act committed before the commencement of the amending regulation may be continued or started as if the amending regulation had not been made.\ns 30 ins 2001 SL No. 174 s 3\n(sec.30-ssec.1) To remove doubt, it is declared that this regulation, as in force immediately before the commencement of the Drugs Misuse Amendment Regulation (No. 2) 2001 (the amending regulation ), continues to apply in relation to an offence against the Act committed before the commencement of the amending regulation.\n(sec.30-ssec.2) Proceedings for an offence against the Act committed before the commencement of the amending regulation may be continued or started as if the amending regulation had not been made.","sortOrder":49},{"sectionNumber":"sec.31","sectionType":"section","heading":"Transitional provision for Drugs Misuse Amendment Regulation (No. 2) 2002","content":"### sec.31 Transitional provision for Drugs Misuse Amendment Regulation (No. 2) 2002\n\nTo remove doubt, it is declared that this regulation, as in force immediately before the commencement of this section, continues to apply in relation to an offence against the Act committed before the commencement of this section.\nProceedings for an offence against the Act committed before the commencement of this section may be continued or started as if the Drugs Misuse Amendment Regulation (No. 2) 2002 had not been made.\ns 31 ins 2002 SL No. 368 s 4\n(sec.31-ssec.1) To remove doubt, it is declared that this regulation, as in force immediately before the commencement of this section, continues to apply in relation to an offence against the Act committed before the commencement of this section.\n(sec.31-ssec.2) Proceedings for an offence against the Act committed before the commencement of this section may be continued or started as if the Drugs Misuse Amendment Regulation (No. 2) 2002 had not been made.","sortOrder":50},{"sectionNumber":"sch.1-pt.1","sectionType":"part","heading":"Non-steroid drugs","content":"# Non-steroid drugs","sortOrder":51},{"sectionNumber":"sch.1-pt.2","sectionType":"part","heading":"Steroid drugs","content":"# Steroid drugs","sortOrder":52},{"sectionNumber":"sch.3-pt.1","sectionType":"part","heading":"Quantities of non-steroid drugs","content":"# Quantities of non-steroid drugs","sortOrder":53},{"sectionNumber":"sch.3-pt.2","sectionType":"part","heading":"Quantities of steroid drugs","content":"# Quantities of steroid drugs","sortOrder":54},{"sectionNumber":"sch.4-pt.1","sectionType":"part","heading":"Quantities of non-steroid drugs","content":"# Quantities of non-steroid drugs","sortOrder":55},{"sectionNumber":"sch.4-pt.2","sectionType":"part","heading":"Quantities of steroid drugs","content":"# Quantities of steroid drugs","sortOrder":56},{"sectionNumber":"sch.8-pt.1","sectionType":"part","heading":"General conditions","content":"# General conditions","sortOrder":57},{"sectionNumber":"sch.8-pt.2","sectionType":"part","heading":"Particular conditions for researcher licences","content":"# Particular conditions for researcher licences","sortOrder":58},{"sectionNumber":"sch.8-pt.3","sectionType":"part","heading":"Particular conditions for grower licences","content":"# Particular conditions for grower licences","sortOrder":59},{"sectionNumber":"sch.8-pt.4","sectionType":"part","heading":"Particular conditions for seed handler licences","content":"# Particular conditions for seed handler licences","sortOrder":60},{"sectionNumber":"sch.8A-pt.1","sectionType":"part","heading":"Substances that include their salts, derivatives and stereo-isomers","content":"# Substances that include their salts, derivatives and stereo-isomers","sortOrder":61},{"sectionNumber":"sch.8A-sec","sectionType":"section","heading":null,"content":"### Section sch.8A-sec\n\nIn this part, a reference to a substance includes a reference to—\na salt, derivative or stereo-isomer of the substance; and\na salt of a derivative or stereo-isomer of the substance.\nSubstance\nAlternative name\nGross weight\nAcetaldehyde\n0.1g\nN-Acetylanthranilic acid\n2-Acetamidobenzoic acid\n0.1g\nAllylbenzene\n3-Phenyl-1-propene or 2-propenyl benzene\n0.1g\n4-Allylpyrocatechol\n0.1g\nAlpha-methyl-3,4- methylenedioxyphenylpropanaldoxime\n0.1g\nAlpha-methyl-3,4- methylenedioxyphenylpropanamide\n0.1g\nAlpha-methylstyrene\n0.1g\nAlpha-phenylacetoacetonitrile (APAAN)\n0.1g\nAmmonium formate\n0.1g\nAnethole\n0.1g\n4-Anilino-N-phenethylpiperidine (ANPP)\n0.1g\nAnthranilic acid\n2-Aminobenzoic acid\n0.1g\nBenzaldehyde\n0.1g\n1,3-Benzodioxole\n0.1g\nBenzyl bromide\nα-Bromotoluene\n0.1g\nBenzyl chloride\nα-Chlorotoluene\n0.1g\nBenzyl cyanide\n0.1g\nBoron tribromide\n0.1g\nBromobenzene\nPhenylbromide\n0.1g\n5-Bromo-1,3-benzodioxole\n3,4-Methylenedioxybromobenzene\n0.1g\nBromo safrole\n0.1g\n1,4-Butanediol\nTetramethylene glycol\n0.1g\n1-Chlorophenyl-2-aminopropane\n0.1g\nChromic acid\n0.1g\nChromium trioxide\nChromium (VI) oxide\n0.1g\nEphedrine\n0.1g\nErgometrine\nErgonovine\n0.1g\nErgotamine\n0.1g\nEthanamine\nMonoethylamine\n0.1g\nN-Ethylephedrine\n0.1g\nEthyl phenylacetate\nBenzeneacetic acid, ethyl ester\n0.1g\nN-Ethylpseudoephedrine\n0.1g\nEugenol\n0.1g\nFormaldehyde\n0.1g\nFormamide\n0.1g\nGamma-Aminobutyric acid (GABA)\n4-Aminobutanoic acid\n0.1g\nHelional\n0.1g\n4-Hydroxybutanal\n4-Hydroxybutyraldehyde\n0.1g\n4-Hydroxybutanoic acid lactone\nGamma-butyrolactone\n0.1g\n4-Hydroxybutanoic acid nitrile\n4-Hydroxybutyronitrile\n0.1g\n4-Hydroxypentanoic acid\nGamma-Hydroxyvaleric acid\n0.1g\n4-Hydroxypentanoic acid lactone\nGamma-valerolactone\n0.1g\n2-Hydroxytetrahydrofuran\nTetrahydro-2-furanol\n0.1g\nHypophosphorous acid\nPhosphinic acid\n0.1g\nIsosafrole\n5-(1-Propenyl)-1,3-benzodioxole\n0.1g\nLithium aluminium hydride\n0.1g\nMandelic acid\nAlpha-Hydroxyphenylacetic acid\n0.1g\nMercuric chloride\nMercury bichloride or Mercury (II) chloride\n0.1g\nMethylamine\nAminomethane or Monomethylamine\n0.1g\nMethylammonium salts\n0.1g\n3,4-Methylenedioxphenylacetic acid\n0.1g\n3,4-Methylenedioxyphenyl- 2-propanone\n0.1g\nN-Methylephedrine\n0.1g\nN-Methylformamide\n0.1g\nMethyl phenylacetate\nBenzeneacetic acid, methyl ester\n0.1g\nN-Methylpseudoephedrine\n0.1g\nNitroethane\n0.1g\nNitromethane\n0.1g\nNorpseudoephedrine\n0.1g\nPalladium\n0.1g\nParamethoxyphenyl-2-propanone\n0.1g\nN-(2-Phenethyl)-4-piperidinone (NPP)\n0.1g\nPhenylacetamide\n0.1g\nPhenylacetic acid\n0.1g\nPhenylacetonitrile\nBenzeneacetonitrile, Benzyl cyanide or Benzyl nitrile\n0.1g\nPhenylacetyl chloride\n0.1g\n1-Phenyl-2-bromopropane\n0.1g\n1-Phenyl-2-chloropropane\n0.1g\n1-Phenyl-2-iodopropane\n0.1g\n1-Phenyl-2-methylaminopropane\n0.1g\n1-Phenyl-2-nitropropene\n0.1g\n1-Phenyl-2-propanol\n0.1g\nPhenylpropanolamine\nNorephedrine\n0.1g\n1-Phenyl-1-propanone\nPhenyl ethyl ketone or Propiophenone\n0.1g\n1-Phenyl-2-propanone\nBenzyl methyl ketone or Phenylacetone\n0.1g\n1-Phenyl-2-propanone oxime\n0.1g\nPiperidine\n0.1g\nPiperonal\nHeliotropine or 3,4-Methylenedioxybenzaldehyde\n0.1g\nPropionic anhydride\n0.1g\nPseudoephedrine\n50g or 1L\nPyridine\n0.1g\n2-Pyrrolidone\nGamma-butyrolactam\n0.1g\nRaney nickel\n0.1g\nSafrole\n5-(2-Propenyl)-1,3-benzodioxide\n0.1g\nSassafras oil\n0.1g\nSodium bis(2-methoxyethoxy) aluminium hydride\n0.1g\nSodium borohydride\n0.1g\nSodium cyanoborohydride\n0.1g\nThionyl chloride\n0.1g\nThorium\n0.1g\nTrans-beta-methylstyrene\n0.1g\n(sch.8A-sec-ssec.1) In this part, a reference to a substance includes a reference to— a salt, derivative or stereo-isomer of the substance; and a salt of a derivative or stereo-isomer of the substance. Substance Alternative name Gross weight Acetaldehyde 0.1g N-Acetylanthranilic acid 2-Acetamidobenzoic acid 0.1g Allylbenzene 3-Phenyl-1-propene or 2-propenyl benzene 0.1g 4-Allylpyrocatechol 0.1g Alpha-methyl-3,4- methylenedioxyphenylpropanaldoxime 0.1g Alpha-methyl-3,4- methylenedioxyphenylpropanamide 0.1g Alpha-methylstyrene 0.1g Alpha-phenylacetoacetonitrile (APAAN) 0.1g Ammonium formate 0.1g Anethole 0.1g 4-Anilino-N-phenethylpiperidine (ANPP) 0.1g Anthranilic acid 2-Aminobenzoic acid 0.1g Benzaldehyde 0.1g 1,3-Benzodioxole 0.1g Benzyl bromide α-Bromotoluene 0.1g Benzyl chloride α-Chlorotoluene 0.1g Benzyl cyanide 0.1g Boron tribromide 0.1g Bromobenzene Phenylbromide 0.1g 5-Bromo-1,3-benzodioxole 3,4-Methylenedioxybromobenzene 0.1g Bromo safrole 0.1g 1,4-Butanediol Tetramethylene glycol 0.1g 1-Chlorophenyl-2-aminopropane 0.1g Chromic acid 0.1g Chromium trioxide Chromium (VI) oxide 0.1g Ephedrine 0.1g Ergometrine Ergonovine 0.1g Ergotamine 0.1g Ethanamine Monoethylamine 0.1g N-Ethylephedrine 0.1g Ethyl phenylacetate Benzeneacetic acid, ethyl ester 0.1g N-Ethylpseudoephedrine 0.1g Eugenol 0.1g Formaldehyde 0.1g Formamide 0.1g Gamma-Aminobutyric acid (GABA) 4-Aminobutanoic acid 0.1g Helional 0.1g 4-Hydroxybutanal 4-Hydroxybutyraldehyde 0.1g 4-Hydroxybutanoic acid lactone Gamma-butyrolactone 0.1g 4-Hydroxybutanoic acid nitrile 4-Hydroxybutyronitrile 0.1g 4-Hydroxypentanoic acid Gamma-Hydroxyvaleric acid 0.1g 4-Hydroxypentanoic acid lactone Gamma-valerolactone 0.1g 2-Hydroxytetrahydrofuran Tetrahydro-2-furanol 0.1g Hypophosphorous acid Phosphinic acid 0.1g Isosafrole 5-(1-Propenyl)-1,3-benzodioxole 0.1g Lithium aluminium hydride 0.1g Mandelic acid Alpha-Hydroxyphenylacetic acid 0.1g Mercuric chloride Mercury bichloride or Mercury (II) chloride 0.1g Methylamine Aminomethane or Monomethylamine 0.1g Methylammonium salts 0.1g 3,4-Methylenedioxphenylacetic acid 0.1g 3,4-Methylenedioxyphenyl- 2-propanone 0.1g N-Methylephedrine 0.1g N-Methylformamide 0.1g Methyl phenylacetate Benzeneacetic acid, methyl ester 0.1g N-Methylpseudoephedrine 0.1g Nitroethane 0.1g Nitromethane 0.1g Norpseudoephedrine 0.1g Palladium 0.1g Paramethoxyphenyl-2-propanone 0.1g N-(2-Phenethyl)-4-piperidinone (NPP) 0.1g Phenylacetamide 0.1g Phenylacetic acid 0.1g Phenylacetonitrile Benzeneacetonitrile, Benzyl cyanide or Benzyl nitrile 0.1g Phenylacetyl chloride 0.1g 1-Phenyl-2-bromopropane 0.1g 1-Phenyl-2-chloropropane 0.1g 1-Phenyl-2-iodopropane 0.1g 1-Phenyl-2-methylaminopropane 0.1g 1-Phenyl-2-nitropropene 0.1g 1-Phenyl-2-propanol 0.1g Phenylpropanolamine Norephedrine 0.1g 1-Phenyl-1-propanone Phenyl ethyl ketone or Propiophenone 0.1g 1-Phenyl-2-propanone Benzyl methyl ketone or Phenylacetone 0.1g 1-Phenyl-2-propanone oxime 0.1g Piperidine 0.1g Piperonal Heliotropine or 3,4-Methylenedioxybenzaldehyde 0.1g Propionic anhydride 0.1g Pseudoephedrine 50g or 1L Pyridine 0.1g 2-Pyrrolidone Gamma-butyrolactam 0.1g Raney nickel 0.1g Safrole 5-(2-Propenyl)-1,3-benzodioxide 0.1g Sassafras oil 0.1g Sodium bis(2-methoxyethoxy) aluminium hydride 0.1g Sodium borohydride 0.1g Sodium cyanoborohydride 0.1g Thionyl chloride 0.1g Thorium 0.1g Trans-beta-methylstyrene 0.1g\n- (a) a salt, derivative or stereo-isomer of the substance; and\n- (b) a salt of a derivative or stereo-isomer of the substance.","sortOrder":62},{"sectionNumber":"sch.8A-pt.2","sectionType":"part","heading":"Substances that do not include their salts, derivatives and stereo-isomers","content":"# Substances that do not include their salts, derivatives and stereo-isomers","sortOrder":63},{"sectionNumber":"sch.8A-sec-oc.2","sectionType":"section","heading":null,"content":"### Section sch.8A-sec-oc.2\n\nIn this part, a reference to a substance does not include a reference to—\na salt, derivative or stereo-isomer of the substance; and\na salt of a derivative or stereo-isomer of the substance.\nSubstance\nAlternative name\nGross weight\nAcetic anhydride\n0.1g\nCalcium metal\n0.1g\nHydriodic acid\nHydrogen iodide solution\n0.1g\nHydrobromic acid\nHydrogen bromide solution\n0.1g\nIodine\n0.1g\nLithium metal\n25g\nMagnesium metal\n0.1g\nMercury metal\n0.1g\nPhosphorous acid\nPhosphonic Acid\n0.1g\nPhosphorus (red or white)\n0.1g\nPlatinum metal\n0.1g\nPotassium metal\n0.1g\nSodium metal\n0.1g\n(sch.8A-sec-oc.2-ssec.2) In this part, a reference to a substance does not include a reference to— a salt, derivative or stereo-isomer of the substance; and a salt of a derivative or stereo-isomer of the substance. Substance Alternative name Gross weight Acetic anhydride 0.1g Calcium metal 0.1g Hydriodic acid Hydrogen iodide solution 0.1g Hydrobromic acid Hydrogen bromide solution 0.1g Iodine 0.1g Lithium metal 25g Magnesium metal 0.1g Mercury metal 0.1g Phosphorous acid Phosphonic Acid 0.1g Phosphorus (red or white) 0.1g Platinum metal 0.1g Potassium metal 0.1g Sodium metal 0.1g\n- (a) a salt, derivative or stereo-isomer of the substance; and\n- (b) a salt of a derivative or stereo-isomer of the substance.","sortOrder":64}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"flash_summary":{"complexity_score":8,"scope_assessment":{"changed":true,"description":"The regulation has expanded and specified the regulatory reach beyond basic controlled‑substance transaction rules to include an operational framework for commercial and research industrial cannabis (pt.4: authorisations, seed certification, labelling, recordkeeping, notification and monitoring fees). New obligations for monitoring fees, inspector travel and recoverable laboratory costs (sec 28A), detailed record and notification regimes for researchers, growers and seed handlers (secs 24–27A), and extensive precursor substance scheduling (sch.8A) indicate a widening in scope and administrative detail compared with a purely transactional control regime. Several provisions also vest administrative discretion in the chief executive and inspectors for authorisations and guidance (secs 11(5), 27B(3)), further changing operational scope."},"complexity_factors":["Extensive cross-references to provisions of the principal Act and other Acts (e.g. Act, Medicines and Poisons Act 2019) creating interdependence across instruments (see secs 3,4,10,11,28A).","Multiple regulated actor categories (licensees, researchers, growers, seed handlers, carriers, DPI researchers, inspectors, analysts, manufacturers, employees, immediate family) with different permissions and limits (secs 12–23).","Detailed recordkeeping, notification and retention rules with short time limits (e.g. 7 days for registers and records, sec 7(2), secs 25(2),26(2); retention periods in sec 27).","Technical scientific requirements for THC testing, representative sampling and use of NATA‑accredited labs, with conditional rules for interstate/overseas seed (sec 11).","Labelling specifications with precise format requirements (language, font size, contrast) (sec 27C).","Fee schedule and partial cost‑recovery mechanism for monitoring, travel and laboratory analysis creates variable fees tied to inspector time and activities (sec 28A, schedule 8E).","Large schedules of named precursor substances with specific gross‑weight thresholds (sch.8A) increasing operational monitoring granularity.","Administrative discretion points: chief executive may publish guidelines and authorise persons, and inspectors exercise operational monitoring and sampling powers (secs 11(5), 27B(3), 28A)."],"plain_english_summary":"What this regulation does, in plain terms\n\n- Mechanically, the Drugs Misuse Regulation 1987 sets out detailed procedures, permissions and record-keeping rules that support and implement parts of the principal Act dealing with: safe disposal of syringes and trace amounts of dangerous drugs (pt.2, secs 3–4); controls on supply of controlled substances and information and identity checks that suppliers must obtain and keep (secs 5–9); and a regulatory framework for commercial production, supply, testing and record-keeping for industrial and research cannabis (pt.4, secs 10–29 and schedules). The regulation also prescribes fees and monitoring arrangements (secs 28–28A, schedule 8E) and lists many specified precursor substances with gross-weight thresholds (sch.8A).\n\nWho is affected\n\n- Suppliers and retailers of controlled substances must collect an end‑user declaration and photographic ID (sec 6), issue invoices at the time of supply (sec 6(4)), keep a register of transactions for at least 2 years (sec 9) and report loss or theft entries in the register (sec 8).\n- People and businesses in the industrial cannabis supply chain — licensees (researchers, growers, seed handlers), DPI researchers, carriers, inspectors, analysts, manufacturers, employees and immediate family members performing necessary tasks — are specifically authorised to possess, produce, supply or transport defined cannabis classes when acting within the conditions set in this regulation (secs 11–23; schedule 8 conditions at sec 29).\n- Holders of relevant authorities pay monitoring fees and possible additional costs for inspector travel and laboratory analysis (sec 28A).\n- The commissioner of the police service receives copies of end‑user declarations (sec 6A).\n\nWhy it matters (official purpose and practical consequences)\n\n- The instrument operationalises statutory controls aimed at tracking and limiting unlawful supply and diversion of controlled substances and regulating an authorised industrial cannabis industry. It provides the mechanics for identity checks, transaction registers, record retention, labelling and THC testing to determine whether seed/plants meet low‑THC (0.5%) criteria (secs 11, 25–27, 27C). The regulation also prescribes monitoring fees and inspection-related recoverable costs (sec 28A).\n\nCompliance costs, incentives and trade-offs\n\n- Compliance burden: Suppliers and licence holders must maintain transaction registers, invoices and detailed production/supply records, and retain records for fixed periods (secs 6–9, 25–27). Seed handlers and researchers must record delivery chains, denaturing actions, planting and disposal methods (secs 25–26). These are direct administrative costs and require systems for timely recording (usually within 7 days) (secs 6(4), 7(2), 25(2), 26(2)).\n- Fees and direct charges: Holders of relevant authorities bear monitoring fees and inspector travel/time charges; they also pay any reasonable laboratory costs if samples are taken (sec 28A). That makes monitoring partly cost‑recoverable to the regulator and directly borne by licensees.\n- Testing and verification dependencies: Determination that seed originates from a plant with ≤0.5% THC relies on analyses by authorised persons or NATA‑accredited laboratories and labelling of seed (sec 11). This creates operational dependence on laboratory capacity and creates potential timing or logistical constraints.\n- Bureaucratic discretion and information control: The chief executive may publish guidelines and may authorise persons for sampling or other functions (secs 11(5), 27B(3)). Inspectors are given monitoring and sample‑taking roles (secs 18–19, 28A). These provisions allocate operational decision‑making to officials and create scope for administrative choices about processes and guidance.\n\nEffects on private behaviour and markets\n\n- The regime channels lawful activity into licensed and documented pathways: authorised carriers, seed handlers, researchers and growers may lawfully move and handle specified cannabis materials while unlicensed actors cannot (secs 12–23). Record and labelling requirements create traceability in the supply chain (secs 11, 27C, 25–26).\n- Supply chain implications: labelling, recordkeeping, and testing introduce transaction costs for seed exporters/importers and for local handlers (secs 11(4), 27C). Monitoring fees and potential sample analysis fees increase operating costs for licensees (sec 28A).\n\nImplementation risks and trade‑offs\n\n- The system depends on timely testing and inspector capacity (secs 11, 28A). Delays or limited lab capacity could affect growers and researchers who must provide test results or notify harvests (sec 27A).\n- There is a trade‑off between enabling authorised industrial/research activity (explicit permissions in pt.4) and imposing administrative and cost burdens to manage diversion and public‑safety risks (multiple provisions throughout pt.4 and secs 6–9).\n\nConcrete points on who pays and who decides\n\n- Who pays: suppliers and licensees bear record‑keeping costs; holders of relevant authorities pay monitoring fees, travel charges and analysis costs (sec 28A); suppliers risk penalty units for failing to invoice as required (sec 6(4)).\n- Who decides and sets process: inspectors and authorised persons carry out inspections, sampling and authorisations (secs 11, 18–19, 28A); the chief executive can publish guidelines and authorise persons for functions under the regulation (secs 11(5), 27B(3)).\n\nKey statutory references (selection)\n- Syringe/disposal procedures: secs 3–4.  \n- Supplier ID, end‑user declarations, invoices and police notification: secs 5–6, 6A, 7–9.  \n- Industrial cannabis authorisations, testing and labelling: secs 10–23, 25–27C.  \n- Monitoring fees and inspector cost recovery: sec 28A.  \n- Specified precursor substances and thresholds: sch.8A.\n\nThis summary is a concise guide to the regulatory mechanics and the primary compliance, cost and operational effects that follow from the cited provisions."},"summary":{"complexity_score":8,"scope_assessment":{"changed":true,"description":"The original 1987 regulation was focused primarily on drug misuse control — needle disposal and dangerous drug procedures. Over time, its scope expanded significantly to include a comprehensive licensing and compliance framework for commercial industrial cannabis (hemp) production (added from 2002 onwards and substantially expanded in 2018), detailed precursor chemical tracking obligations for businesses, and a fee-recovery scheme for government monitoring. What began as a narrow procedural instrument has become a multi-purpose regulatory framework covering an entirely new lawful industry (industrial hemp) alongside its original drug harm-reduction purpose."},"complexity_factors":["Multiple distinct regulatory regimes combined in one instrument (needle disposal, precursor chemicals, industrial cannabis)","Extensive cross-referencing to the parent Act (Drugs Misuse Act 1986) and other legislation (Medicines and Poisons Act 2019), requiring readers to consult multiple documents","Large number of defined categories of persons with different rights and obligations (growers, researchers, DPI researchers, carriers, inspectors, analysts, manufacturers, seed handlers, family members, employees)","Complex classification system for cannabis (industrial cannabis, class A and B research cannabis, planting seed, processed cannabis) with different rules for each","Multiple schedules containing technical chemical lists, quantity thresholds, and fee structures not fully reproduced in the main body","Technical chemical terminology in Schedule 8A (precursor chemicals) requires specialist knowledge","Numerous amendments over 35+ years (1987–2022) creating a patchwork of renumbered and substituted provisions that are difficult to trace","THC concentration testing requirements involving specific scientific processes (NATA accreditation, representative sampling) and technical thresholds","Varying time limits for different obligations (7 days, 14 days, 3 months, 4 weeks, 2 years, 3 years) creating compliance complexity","Fee calculation methodology for monitoring fees involves fractions of hours (15-minute increments) and travel time caps"],"plain_english_summary":"## Drugs Misuse Regulation 1987 (Queensland)\n\n### What is this?\nThis is a Queensland regulation that sits underneath the *Drugs Misuse Act 1986* and fills in the practical details of how that law is enforced and administered. It covers three main areas:\n\n---\n\n### 1. Safe disposal of needles and dangerous drugs\nIf you find or possess a hypodermic needle or syringe, this regulation tells you the **two legal ways to get rid of it safely**:\n- Put it in a **rigid, puncture-resistant container** that is sealed so it can't hurt anyone; OR\n- Hand it to a **doctor, pharmacist, or other authorised person**.\n\nIf you find a dangerous drug (not just a trace amount), you must hand it to an **authorised inspector** as soon as reasonably possible.\n\n---\n\n### 2. Controlled substances (chemicals used to make illegal drugs)\nIf your business supplies certain chemicals that can be used to manufacture illegal drugs (called **\"controlled substances\"** — things like ephedrine, which is found in cold medicine but can be used to make methamphetamine), you must:\n- Get detailed paperwork (called an **\"end user declaration\"**) from whoever you're selling to, including their name, address, ID details, and why they need it\n- Check photo ID if you're selling to an individual\n- Issue an invoice immediately after the sale\n- **Send a copy of the declaration to the Police Commissioner** as soon as possible\n- Keep detailed records in a register (within 7 days of the transaction)\n- Report any theft or loss to police and record it\n- Keep all records for **2 years** at your main Queensland business location\n\nBreaching some of these requirements can result in fines (up to 20 penalty units — currently around $3,000 in Queensland).\n\n---\n\n### 3. Industrial hemp/cannabis production (low-THC cannabis)\nThis is the most complex part. Queensland allows **licensed** growing and research of industrial cannabis (hemp) — a type of cannabis plant with very low levels of THC (the chemical that gets you high — no more than 0.5%). This section sets out who can legally handle this plant material and under what conditions.\n\n**Who is covered:**\n- **Growers and researchers** (licensed by the government)\n- **Seed handlers** (who process hemp seeds)\n- **Carriers** (truck drivers/couriers who transport the plants/seeds for licensed people)\n- **DPI researchers** (Department of Primary Industries scientists)\n- **Inspectors** (government officials)\n- **Manufacturers** (factories using hemp to make products)\n- **Analysts** (scientists who test THC levels)\n- **Family members and employees** of licensed people (if their involvement is necessary for the licensed activity)\n\n**Key requirements for licensees:**\n- Detailed written records must be kept of all plants, seeds, supply transactions, deliveries, and destruction/disposal (within 7 days of events occurring)\n- Notify an inspector **within 14 days** of planting cannabis seed\n- Notify inspector at least **4 weeks before harvest** for THC testing\n- Seeds must be tested and **labelled** with specific THC test results before planting\n- Research licence applications must include a detailed **security and risk management plan**\n- **Monitoring fees** must be paid to cover the cost of government inspectors overseeing your operation (including travel time up to 2 hours/day)\n- Records must be kept for **2-3 years** after the authority/licence ends\n\n---\n\n### Who does this affect?\n- **Pharmacies, chemical suppliers, and industrial businesses** dealing in substances that could be used to make drugs\n- **Hemp farmers and cannabis researchers** in Queensland\n- **Freight companies** transporting hemp\n- **Scientists and analysts** testing cannabis THC levels\n- Ordinary people may be affected by the needle disposal rules\n\n---\n\n### Schedules (lists attached to the regulation)\nThe regulation includes lists of:\n- Specific drugs classified as dangerous\n- Quantity thresholds for offences\n- Chemicals that are \"controlled substances\" (precursors to illegal drugs), like ephedrine, pseudoephedrine, and many industrial chemicals\n- Licence conditions for hemp growers and researchers\n- Fee schedules"},"issue_detection":{"absurdities":[{"type":"circular_definition","section":"sec.6(2)(b)","severity":"medium","reasoning":"Section 6(2)(b) requires the end user declaration to contain details of the official document produced under s6(3), but s6(3) only mandates production of an identity document when the recipient is an individual. For corporate recipients, no document is required under s6(3), making s6(2)(b) impossible to comply with literally, or rendering it a nullity for non-individual recipients. The regulation does not provide an alternative or exemption for this gap.","confidence":0.82,"description":"Circular pre-supply requirement: the end user declaration must include 'details of the official document produced by the recipient under subsection (3)', but subsection (3) only applies 'if the recipient is an individual'. If the recipient is a company, subsection (3) is never triggered, yet subsection (2)(b) still requires details of a document that was never required to be produced."},{"type":"self_contradicting","section":"sec.4(b)","severity":"low","reasoning":"Section 4(a) covers 'trace amount of a dangerous drug contained in a hypodermic syringe or needle'. Section 4(b) is 'any other case' but then includes a sub-provision s4(b)(ii) for when the thing is 'contained in a hypodermic syringe or needle'. If it is in a syringe, it should be a trace amount caught by s4(a); s4(b)(ii) presupposes a non-trace dangerous drug in a syringe in the 'other case', which creates an unaddressed logical gap about what constitutes a non-trace drug in a syringe and why that case would not fall under s4(a).","confidence":0.65,"description":"Structural impossibility in disposal of dangerous drugs: section 4(b)(ii) requires giving 'where such thing is contained in a hypodermic syringe or needle, such syringe or needle' to an inspector, but section 4(a) already deals with the case where a dangerous drug is contained in a syringe or needle (trace amounts). Section 4(b) is the catch-all for 'any other case', yet it re-envisages the scenario of a thing contained in a syringe or needle which should already have been exhausted by s4(a)."},{"type":"self_contradicting","section":"sec.27(1)","severity":"medium","reasoning":"In the most common scenario—an authority expiring—the holder stops being the holder at the same moment the authority ends, meaning both periods commence simultaneously. Period (b) (2 years) will always expire before period (a) (3 years), making (a) dead letter. The only scenario where (a) could apply is if the authority continues to exist but the holder changes (e.g. transfer), but 'the authority ends' and 'the holder stops being the holder' are not clearly distinguished as separate events in the regulation, creating confusion about legislative intent.","confidence":0.75,"description":"Logical absurdity in record retention: the holder must keep records until 'the end of the first of the following periods'—(a) 3 years after the authority ends, or (b) 2 years after the holder stops being the holder. However, if the holder stops being the holder because the authority ends, both periods are triggered simultaneously, and 'the first to end' would always be the 2-year period in (b), rendering the 3-year period in (a) entirely redundant and never operative in practice."},{"type":"other","section":"sec.6(4) and sec.6A(2)","severity":"low","reasoning":"While not strictly impossible, the interplay of pre-supply obligations (obtain declaration, forward to police 'as soon as practicable') and the requirement to make an invoice 'immediately' upon supply creates practical tension. The phrase 'as soon as practicable' in s6A could be interpreted as requiring police notification before supply occurs, which would impose an unlisted pre-condition on supply not expressly stated.","confidence":0.55,"description":"Temporal impossibility in combined compliance: section 6(4) requires the invoice to be made 'immediately' upon supply, while section 6A(2) requires a copy of the end user declaration to be given to the police commissioner 'as soon as practicable after obtaining' the declaration. The end user declaration under s6(2) must be obtained before supply, and the invoice must be made immediately upon supply. If the supplier is required to forward the declaration to police before proceeding (to comply as early as possible), this may delay supply, but the regulation provides no sequencing guidance, creating operational ambiguity."},{"type":"other","section":"sec.11(4)(a)(i)","severity":"low","reasoning":"Section 11 provides two equivalent pathways for Queensland-origin seed certification (ss(2) and ss(3)), yet the interstate/overseas equivalence in ss(4) only refers to the pathway in ss(3)(a)(i). This creates an asymmetry where an analysis equivalent to the ss(2) pathway would technically not satisfy the imported seed standard, even though it is equally valid for domestic seed.","confidence":0.68,"description":"Interstate seed relies on equivalence to a provision that itself has two alternative paths: section 11(4)(a)(i) requires that imported seed has undergone analysis 'substantially equivalent to an analysis mentioned in subsection (3)(a)(i)'. Subsection (3)(a)(i) refers only to one of two pathways for in-State seed (the inspector-arranged analysis), ignoring the equally valid pathway in s11(2)(a)(i). There is no explanation for why the interstate equivalence test references only one of the two valid domestic pathways."},{"type":"self_contradicting","section":"sec.25(1)(i)(iii)","severity":"low","reasoning":"The parenthetical exclusion of 'processed cannabis' from what are described as 'cannabis plants or seed' is tautological—processed cannabis is by definition not cannabis plants or seed. The exclusion is therefore meaningless and suggests a drafting error, possibly intended to exclude processed cannabis from a differently scoped provision.","confidence":0.72,"description":"Category confusion in supply records: section 25(1)(i)(iii) requires the licensee to record 'for cannabis plants or seed that is not processed cannabis—particulars of how the cannabis plants or seed was grown, or otherwise obtained'. This provision is within a list item about supplying cannabis plants or seed to another person, and the qualifier 'that is not processed cannabis' is logically incoherent because 'processed cannabis' is definitionally distinct from 'cannabis plants or seed'—processed cannabis cannot simultaneously be cannabis plants or seed."},{"type":"other","section":"sec.23(2) — authorised person definition","severity":"low","reasoning":"A carrier only has authorisation when engaged by specified persons (s12). Section 23 authorises the carrier's employee if 'under the Act, the authorised person [carrier] is authorised'. If the carrier's engagement lapses or was invalid, the employee's derivative authority also falls away—but s23 on its face creates a secondary authorisation that may not adequately inherit the engagement preconditions from ss12-13.","confidence":0.5,"description":"Employees of a 'carrier' are authorised to transport cannabis under s23, but a carrier's own authorisation in s13 is conditional on being engaged by specific persons (researcher, grower, DPI researcher, inspector, seed supplier). Section 23 authorises a carrier's employee to transport based solely on the carrier's authorisation, without requiring the carrier's underlying engagement conditions to be independently satisfied by the employee—potentially extending the authorisation chain beyond its intended scope."}],"contradictions":[{"severity":"medium","section_a":"sec.6(2)","section_b":"sec.6(3)","confidence":0.8,"description":"Section 6(2) requires the end user declaration to be obtained before supply and must include details of the identity document 'produced by the recipient under subsection (3)'. However, s6(3) only requires production of an identity document if the recipient is an individual. For corporate recipients, no document is produced under s6(3), making s6(2)(b) both mandatory in form but impossible in substance for non-individual recipients."},{"severity":"low","section_a":"sec.4(a)","section_b":"sec.4(b)(ii)","confidence":0.62,"description":"Section 4(a) directs that where a dangerous drug is a trace amount in a syringe or needle, disposal is under s3. Section 4(b) covers 'any other case' yet s4(b)(ii) re-contemplates the scenario of a thing 'contained in a hypodermic syringe or needle'. These two provisions create an overlapping and potentially contradictory scope: a non-trace dangerous drug in a syringe is captured by s4(b) generally but s4(b)(ii) then creates a requirement to hand over the syringe as well—which conflicts with s4(a)'s complete regime for drug-in-syringe scenarios."},{"severity":"medium","section_a":"sec.27(1)(a)","section_b":"sec.27(1)(b)","confidence":0.73,"description":"The record retention trigger of 'the first of the following periods' creates a contradiction in intent: (a) prescribes 3 years after the authority ends, and (b) prescribes 2 years after the holder stops being the holder. Because stopping being the holder almost always co-occurs with or precedes the authority ending, (b) will structurally always produce the shorter period, rendering (a) operative only in a hypothetically narrow scenario (authority still extant, holder changes) that may not be contemplated under the licensing scheme—making (a) and (b) functionally contradictory in purpose."},{"severity":"low","section_a":"sec.9(2)(b)","section_b":"sec.27(1)","confidence":0.58,"description":"Section 9 requires documents for controlled substance transactions to be kept for 2 years from the day of supply. Section 27 requires cannabis-related records to be kept for either 3 years after the authority ends or 2 years after the holder stops being the holder (whichever is first). Where an activity involves both controlled substances and cannabis (e.g. a researcher also dealing in controlled substances), the retention periods are inconsistent and potentially contradictory—documents may be destroyed under s9 while still required under s27, or vice versa."},{"severity":"low","section_a":"sec.11(2)","section_b":"sec.11(3)","confidence":0.65,"description":"Sections 11(2) and 11(3) both provide alternative pathways for Queensland-origin cannabis seed to be certified as planting seed, yet s11(4) (interstate/overseas seed equivalence) only references s11(3)(a)(i) as the comparator standard. This creates an internal contradiction: both ss(2) and ss(3) are equally valid domestic certification pathways, but only ss(3) is recognised as the benchmark for imported seed equivalence, implying ss(2) is somehow inferior or not a true standard—contradicting the equal standing of the two pathways in the domestic context."}]},"kimi_summary":{"content_quality":"ok","complexity_score":7,"scope_assessment":{"changed":true,"description":"The regulation has expanded significantly beyond its original 1987 scope. Initially focused on dangerous drug disposal procedures and basic controlled substances tracking, it has grown to include a comprehensive industrial cannabis licensing and monitoring regime (Part 4, added substantially in 2002 and expanded in 2018), detailed precursor chemical controls (Schedule 8A), and complex fee structures for monitoring. The original short regulation has become a detailed administrative code covering hemp production, research programs, seed certification, and multi-agency coordination between police, health departments, and agriculture departments."},"complexity_factors":["Extensive cross-referencing to the Drugs Misuse Act 1986 and Medicines and Poisons Act 2019","Multiple overlapping categories of cannabis (industrial, class A research, class B research, processed) with different rules for each","Nested conditional requirements for seed certification involving NATA accreditation, authorised persons, and interstate/international distinctions","Detailed administrative requirements including 7-day recording deadlines, 2-3 year retention periods, and specific notification timeframes (14 days, 3 months, 4 weeks)","Schedule 8A contains a complex table of precursor chemicals with varying threshold quantities and different treatment of salts/derivatives between Part 1 and Part 2","Multiple defined terms referenced in Schedule 9 dictionary (not fully shown in extract)","Layered authorisations for different classes of persons (carriers, DPI researchers, inspectors, family members, employees) with specific limitations on each","Prescriptive physical labelling requirements (1.5mm character height, contrast ratios, positioning)","Amendment history showing significant restructuring in 2002 and 2018, indicating evolutionary complexity"],"plain_english_summary":"This regulation sets out detailed rules for handling dangerous drugs and controlled substances in Queensland, with a particular focus on industrial cannabis (hemp) production and precursor chemicals used to make illicit drugs.\n\n**What it covers:**\n\n**1. Safe disposal of syringes and drugs (Sections 3-4)**\n- Tells people how to safely throw away used needles and syringes: either in a tough, puncture-proof container, or by giving them to a doctor, pharmacist, or other authorised person.\n- Sets rules for disposing of dangerous drugs: trace amounts in syringes follow the needle disposal rules; everything else must be handed over to a Medicines and Poisons inspector.\n\n**2. Controlled substances tracking (Sections 5-9)**\n- Requires businesses dealing with \"controlled substances\" (chemicals that can be used to make illegal drugs) to keep strict records.\n- Before supplying these chemicals, sellers must obtain an \"end user declaration\" showing who is buying it, what for, and proof of ID (like a driver's licence).\n- Sellers must give copies of these declarations to the Police Commissioner.\n- Detailed record-keeping requirements include maintaining registers for at least 2 years, recording losses or thefts, and creating invoices for every transaction.\n\n**3. Industrial cannabis (hemp) production (Sections 10-27C)**\n- Creates a licensing framework for growing low-THC cannabis (industrial hemp) for commercial purposes.\n- Defines \"planting seed\" and requires THC testing (maximum 0.5% THC) by authorised persons or NATA-accredited labs.\n- Authorises specific activities for different roles: carriers can transport cannabis, DPI researchers can conduct breeding programs, inspectors can take samples for testing, and manufacturers can process hemp.\n- Sets comprehensive record-keeping rules for researchers, growers, and seed handlers (what strains, quantities, sources, deliveries, planting dates, etc.).\n- Requires notification to inspectors about planting, non-harvested crops, and pre-harvest testing.\n- Mandates specific labelling requirements for cannabis seeds (English text, minimum 1.5mm height, contrast requirements).\n- Allows family members and employees of licensees to assist with authorised activities.\n\n**4. Fees and conditions (Sections 28-29)**\n- Sets out monitoring fees for inspectors checking licensed activities, including travel time and laboratory analysis costs.\n- References schedules containing licence conditions and specific fees.\n\n**5. Precursor chemicals (Schedule 8A)**\n- Lists hundreds of precursor chemicals (like pseudoephedrine, ephedrine, safrole, and various acids and solvents) with their threshold quantities.\n- Distinguishes between substances where salts and derivatives are included versus those where they are not.\n\n**Who it affects:**\n- Pharmacists, doctors, and medical businesses disposing of needles or dangerous drugs.\n- Businesses supplying precursor chemicals (pharmacies, chemical suppliers).\n- Farmers and researchers growing industrial hemp.\n- Transport companies moving cannabis products.\n- Government inspectors and analysts monitoring compliance.\n\n**Why it matters:**\nThis regulation sits under Queensland's Drugs Misuse Act 1986 and provides the operational detail for that law. It aims to prevent drug diversion (stopping legal chemicals becoming illegal drugs), ensure public safety through proper medical waste disposal, and allow a regulated industrial hemp industry while preventing illicit cannabis production through strict THC limits and tracking."}},"importantCases":[],"_links":{"self":"/api/acts/drugs-misuse-regulation-1987","history":"/api/acts/drugs-misuse-regulation-1987/history","analysis":"/api/acts/drugs-misuse-regulation-1987/analysis","conflicts":"/api/acts/drugs-misuse-regulation-1987/conflicts","importantCases":"/api/acts/drugs-misuse-regulation-1987/important-cases","documents":"/api/acts/drugs-misuse-regulation-1987/documents"}}